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Abstract 
 
 The large number of inexpensive carboxylic acids found in nature has spurred research to 
convert carboxylic acids to an assortment of other functional groups for a range of purposes.  To 
accomplish this, researchers employ a variety of strategies ranging from heat and heavy metals to 
biocatalysts.  Ferulic acid decarboxylase (FDC1) from Saccharomyces cerevisiae is a member of 
the UbiD family of decarboxylase enzymes.  The UbiD family of proteins consists of prenylated 
flavin (PrFMN)-dependent enzymes that catalyze the reversible decarboxylation of a wide 
variety of aromatic carboxylic acids.  The UbiD family attracted interest as a biocatalyst to 
produce chemical feedstocks from renewable sources and as a potential target for antimicrobial 
research.  
 The UbiD enzyme, FDC1, and its associated protein partner, PAD1, were identified as 
being responsible for the detoxification of aromatic carboxylic acids in fungi. How PAD1/FDC1 
work together to facilitate the decarboxylation of toxic aromatic acids remains an open question.  
The genes encoding PAD1 and FDC1 were independently expressed in E. coli with the PAD1 
homolog UbiX knocked out.  Independently, FDC1 and PAD1 were unable to decarboxylate 
phenylacrylic acids.  Moreover, PAD1 failed to decarboxylate any of the phenylacrylic acids by 
itself.  In contrast FDC1 was able to recover its decarboxylase activity upon the addition of 
PAD1 or its homolog UbiX, indicating FDC1 was solely responsible for the decarboxylase 
activity.  Co-expression of FDC1 and PAD1 coupled with the sole purification of FDC1 
exhibited spectral characteristics of a reduced flavin in an aerobic system.  This increased the kcat 
by 8-fold. 
  
xix 
 
 The holo-FDC1 crystal structure (PDB 4ZAC) provided insight into the decarboxylation 
mechanism of FDC1.  FDC1 was proposed to perform a unique and controversial 1,3-dipolar 
cycloaddition mechanism. To address the controversial nature of the proposed mechanism KIE 
and a Hammett analysis were utilized to ascertain whether FDC1 undergoes the proposed 
mechanism or a completely different mechanism.  The solvent isotope effects, normal secondary 
isotope effects, and the negative slope of the Hammett analysis are consist with the rate-
determining step being the breakdown of the PrFMN-product adduct through a non-concerted 
cyclo-elimination reaction, and provides evidence in favor of the novel 1,3-dipolar  cycloaddition 
mechanism. 
 The proposed mechanism involves the formation of a novel pentacyclic intermediate 
through a novel 1,3-dipolar cycloaddition mechanism between PrFMN and the β -γ double bond 
of the substrate, which serves to activate the substrate towards decarboxylation.  In order to trap 
this hypothesized intermediate, a mechanism-based inhibitor 2-fluoro-2-nitro-vinylbenzene 
(FNVB) was used to trap the putative cyclo-addition intermediate.  Upon incubating FNVB with 
FDC1, there was a red-shift in the flavin spectrum which is reminiscent of an uncharged N5, C4α 
dialkyl flavin adduct and is consistent with a 1,3-dipolar cycloadduct.  Finally by pushing the 
equilibrium of the FDC1 reaction to favor the formation of product-PrFMN adducts:  7dstyrene-
PrFMN and styrene-PrFMN intermediates were isolated and characterized by Tandem Native 
Mass Spectrometry. 
 FDC1 decarboxylates phenylacrylic acids by forming a novel 1,3-dipolar cycloaddition 
adduct, followed by a Grob fragmentation, protonation of the intermediate, re-cyclization 
between the PrFMN and the product, then finally product release.  This work lays the 
  
xx 
 
groundwork for developing new biocatalysts from these UbiD decarboxylases and the 
development of a new class of antifungal or antibiotics drugs. 
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Chapter 1 
 
  Introduction 
 
1. Sustainability 
 
As the global population approaches the United Nations prediction of 9 billion by 2050, 
perhaps the most significant and imminent challenge facing humanity is that of sustainability.  In 
the last one hundred and fifty years, the exponential growth of our population, globalization of 
communication, and economic networks has been driven by fossil fuels, ancient carbon reserves 
derived from animals and plant matter long decayed[1]. These resources are finite and will likely 
deplete by the end of the current century.  The increasing scarcity of these resources will result in 
an increase in international conflicts over what little of these resources remain.  To avert the 
Figure 1.1-United Nations projected world population growth mode.  The blue line shows the median, the green and 
red lines are based on high and low predictions[1]. 
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political and economic catastrophe that would result upon the depletion of fossil fuels, 
sustainable solutions are urgently needed.  A major focus of these efforts is developing 
alternative synthetic solutions for a variety of high-value compounds derived from fossil fuels 
including, alkanes, polyaromatic compounds, and vinylbenzene derivatives. 
 
1.1.  Carboxylic Acids as a Renewable Chemical Feedstock 
 
 Carboxylic acids are available inexpensively from a wide variety of synthetic and natural 
sources such as lignin. Lignin is a class of organic polymers, particularly prevalent in plant cell 
walls and vascular tissue, consisting of primarily cross-linked phenolic polymers, which when 
broken down under oxidative conditions yield a wide array of aromatic carboxylic acids. They 
are easy to store and handle and have long served as a versatile connection point in the 
construction of carbon frameworks, and as a chemical feedstock for the production of valuable 
commodity chemicals[2]. Carboxylic acids are highly prevalent in biomass, which currently 
make up the greatest proportion of renewable raw materials in the chemical industry[2-5].  These 
materials offer a sustainable feedstock that provides a large number of possibilities that exceed 
the opportunities provided by petrochemistry[6]. Currently more than 90% of the oleochemical 
reactions involving these biorenewable materials involve carboxylate groups.  To utilize these 
materials, synthetic chemists employ numerous biotechnological and chemical techniques to 
transform these materials into commodity chemicals including polymer building blocks and food 
preservatives.   
  One valuable class of carboxylic acids are phenylacrylic carboxylic acids, which are 
prevalent in lignin biomass.  Phenylacrylic acids need to be depolymerized from the lignin 
biomass and then be decarboxylated, which often involves chemically harsh or energetically 
costly processes, both of which will be detailed later in this chapter. Finally, the phenylacrylic 
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acids are transformed into commodity chemicals such as polystyrene, which currently constitutes 
a growing $40 billion market[6-8].  Styrene and styrene derivatives serve as monomers for a 
variety of polymers including: high impact plastics, styrene sulfonate polymers for medical uses, 
and as a general building material.  Other valuable vinyl benzene derivatives include vinyl 
guaiacol, a food preservative, and vinyl phenol, which serves as a building block to a wide 
variety of anthromycin derivatives, which can be used as a food additive or as an n-junction 
material in dye-sensitized solar cells.  Carboxylic acids provide a cheap, stable, and renewable 
chemical feedstock for a variety of commodity compounds and are thus of great interest to the 
chemical industry[8].  
1.2. Chemical Synthetic Strategies for Aromatic Carboxylic Acid Decarboxylation 
 
 A conventional strategy to decarboxylate materials from renewable chemical feedstocks 
to valuable products is to heat these compounds up to 150 ºC-200 ºC in the presence of sodium 
hydroxide or another base.  However many aliphatic and aromatic carboxylic acids only give 
yields approximating 5-10%, which is ineffective for mass scale production[9-11]. 
  In order to decarboxylate a wider variety of substrates, chemists and chemical 
engineers often use a heavy metal catalyst to stabilize the carbanion that results from 
decarboxylation.  A range of aryl and heteroaryl decarboxylation yields were improved using a 
copper(I)oxide and 1,10-phenanthroline at 5 mol% catalytic loading; this resulted in an increase 
in yield from 5-10% upwards to 98% yield over the timescale of minutes.  Further improvement 
of yields was accomplished using different heavy metals such as palladium or platinum[11, 12].    
Unfortunately, all the conventional chemical decarboxylation processes that possess high yields 
suffer from several disadvantages including using heavy metal catalysts, being energetically 
costly, and requiring harsh organic solvents such as quinoline[10].  These disadvantages prevent 
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these decarboxylation processes from being industrially sustainable, thus spurring the search for 
a low-cost alternative to decarboxylate aromatic carboxylic acids to produce aromatic 
compounds. 
1.2. Biochemical Strategies for Aromatic Carboxylic Acid Decarboxylation 
 
 1.2.1. Advantages of Using Enzymes for Decarboxylation 
 
 Enzymes offer solutions to the problems of conventional chemical synthetic routes.  
Enzymes are very efficient catalysts catalzye reactions 10
8
-10
12
 times faster than those of the 
corresponding non-catalyzed reactions and are thus exceed the rate enhancement values that 
chemical catalysts are capable of achieving[13, 14].  Therefore, chemical catalysts are generally 
employed at a 0.1-1 mol% of catalyst loading, whereas most enzymatic reactions can be 
performed with a mole percentage of 0.001-0.0001 mol%. However, enzyme preps are usually 
significantly more expensive than small molecule catalysts.  Enzymes are environmentally 
benign unlike the metal catalysts that present in conventional synthesis, and act under 
environmentally benign conditions.  Enzymes exhibit the highest activity in near physiological 
conditions in water, typically around pH 7, and preferably around 30 ºC.  This minimizes the 
problems of undesired side-reactions such as decomposition, isomerization, racemization, and 
rearrangement.  In synthetic decarboxylation chemistry, the high temperatures required result in 
the destruction of other sensitive groups including amino, ether, ester, and other carboxylic acid 
groups.  Enzymes, on the other hand, act on a single functional group, while leaving other 
sensitive functionalities intact. In addition, due to their complex three-dimensional structure, 
enzymes can distinguish between functional groups that are chemically identical but situated in 
different positions within the same substrate molecule[4, 14]. 
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1.2.2. Problems with Biocatalysts 
 
 Enzymes exhibit a few general disadvantages as well as a few specific disadvantages in 
the area of aromatic carboxylic acid decarboxylation.  Enzymes require narrow operation 
parameters, requiring conditions near their optimal temperature and pH.  Therefore, if a reaction 
proceeds slower than industrially desired under these narrow parameters, there is only a small 
window for alteration.  Elevated temperatures and extreme pH values lead to the deactivation of 
the protein, as do high salt concentration.  Hence these narrow operation conditions prevent 
radical changes.  Enzymes also often exhibit their highest catalytic activity in water, but due to 
the high boiling point, high heat of vaporization, and its tendency to promote corrosion, water is 
often considered to be the least suitable solvent for organic reactions.  Furthermore, the majority 
of organic compounds exhibit poor solubility in water.  Thus, enzyme reactions that perform 
organic transformations either need to use a biphasic solvent system or perform the organic 
reaction in organic solvents.  Both of these cases often result in enzymes exhibiting lesser 
activity relative to native reaction conditions, usually by an order of magnitude.   
 Aromatic carboxylic acid decarboxylases seem to be prone to the tight binding of 
substrate and product molecules.  This tight binding causes a drop in the reaction rate at elevated 
substrate or product concentrations.  This drop in the reaction rate limits the efficiency of the 
process. While substrate tight binding can be easily solved by introducing substrate at a steady 
rate, product inhibition can be more complex to solve. Specifically, aromatic acid decarboxylases 
seem to be prone to product inhibition.  
1.2.3.  How can Aromatic Carboxylic Acid Decarboxylases be Improved? 
  To solve the issue of product inhibition, researchers explored the use of an organic phase 
in a biphasic reactor to remove the more lipophilic products.  Agitation of the reactor causes the 
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more lipophilic products to cross the aqueous/organic membrane thus removing the product from 
the aqueous phase where the enzymatic reaction occurs. 
 A second issue is that most enzymes are often unable to operate at temperatures above  
37 ºC.  Higher temperatures would increase the activity, and the yield of these enzymes, and thus 
make more appealing catalysts for these decarboxylation processes.  Fortunately, success in 
addressing these issues was made through the advent of site-specific mutagenesis by Michael 
Smith.  Site-specific mutagenesis provides a method by which enzymes can be redesigned using 
structure and sequence information which result in enhanced properties[15].  A notable success 
story involves the enhancement of the thermostability of xylanase from Aspergillus niger 
BCC14405. By substituting surface serine and threonine residues with arginine, researchers were 
able to increase the activity of the enzyme at 50 ºC from 15% of its native activity to 80% of its 
native activity[16]. 
 Consequently, a technique that has gained much support in addressing issues unique to 
enzymes is rational design.  Rational design involves precise changes in amino acid sequence 
and protein structure based on precise knowledge of the structure and mechanism of these 
enzymes[17].  Phenylacrylic acid decarboxylases such as the PAD family or the UbiD family 
could be targets for rational design. With the crystal structure available for several UbiD/UbiX 
derivative enzymes, as well as some initial characterization of mechanism for the PAD family 
[18-21], it is certainly feasible to use rational design to improve these decarboxylase enzymes. 
 
1.2.4. Whole-cell Conversion of Phenylacrylic Acids 
 
 Numerous whole-cell platforms exist to decarboxylate a variety of phenylacrylic acids 
including Saccharomyces cerevisiae, Escherichia coli, Aspergillus niger, and Bacillus pumilus. 
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These systems have either been studied to investigate decarboxylation pathways to break down 
phenylacrylic acids or engineered to improve their activity[22-32].  
 One of the earliest systems studied was the breakdown of ferulic acid by A. niger.  
Ferulic acid is one of the most abundant phenolic compounds, present in most plants, and is well 
known for its antioxidant and antifungal properties. As a result, bacteria and fungi present in 
ruminant animals developed mechanisms to breakdown ferulic acid[26, 33, 34].  Baqueiro-Pena 
provided an analysis on how two strains of A. niger, the diploid strain DAR2 and the wildtype 
strain, break down ferulic acid.  The main difference was that the wild type produced both 
vanillic acid and vinyl guaiacol, while the diploid mainly produced vinyl guaiacol. This 
suggested that the diploid strain of A. niger more readily performed a non-oxidative 
decarboxylation of ferulic acid to vinyl guiacol. Baquiero-Pena hypothesized that the 
decarboxylation of ferulic acid was part of a detoxification system similar to that of 
Paecilomyces variotii or Pestalotia palmarum which is designed to maintain ferulic acid and 
similar inhibitory compounds under a threshold concentration[25].  The breakdown of these 
inhibitory compounds was dependent on the presence of two gene products PadA1 and OhbA1, 
which are orthologs to the gene products UbiX and UbiD respectfully and are responsible for the 
decarboxylation of 3-octaprenyl-4-hydroxybenzoic acid[27].  Substrate profiling in A. niger 
indicated that OhbA1/PadA1 decarboxylase system exhibits broad activity with a number of 
aromatic and sorbic acid analogs, indicating that this decarboxylation system is promiscuous in 
order to protect the fungus from the many xenotoxins that it may encounter[27].   
 The first engineered whole-cell system that catalyzed the decarboxylation of ferulic acid 
to 4-vinyl guaiacol was in B. pumilus in a two phase aqueous-organic system[28]. Whole-cells 
expressing the ferulic acid decarboxylase appeared to require no cofactor and exhibited specific 
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activity of 0.22 µM/min and a KM of 7.9 mM for ferulic acid.  Ferulic acid has a high water 
solubility, whereas its decarboxylated product, vinyl guaiacol, is poorly soluble. However, vinyl 
guaiacol has been reported to inhibit the enzyme.  In an effort to increase the yield of vinyl 
guaiacol, Lee et al. decided to employ a 2-phase reaction system to remove the product of the 
reaction; this resulted in a considerable (300%) increase in activity[28].   
 In an effort to lower the costs of these whole-cell systems, McKenna et al. devised a 
novel synthetic route for styrene from renewables using glucose as the substrate[22, 35].   The 
proposed styrene pathway utilizes endogenously synthesized L-phenylalanine as the precursor 
metabolite that could be converted to styrene in two enzymatic steps (Figure 1.2).  First, L-
phenylalanine is converted to TCA through deamination, as catalyzed by phenylalanine ammonia 
lyase (PAL).  The second step in the proposed styrene biosynthesis pathway involves the 
decarboxylation of TCA by a ferulic acid decarboxylase (FDC1) from S. cerevisiae to yield 
styrene as its final product.  TCA decarboxylase activity in S. cerevisiae is dependent on the 
overexpression of two gene products PAD1 and FDC1.  FDC1 from S. cerevisiae shares 
significant genetic similarity with previously established OhbA1 and UbiD enzymes of A. niger 
and E. coli respectively[27,22, 35].      
 
Figure 1.2  Pathway from renewable sugar to styrene proposed by McKenna et al[22]. 
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 These whole-cell platforms to decarboxylate phenylacrylic acids, unfortunately, suffer 
from critical flaws that preclude the use of these biocatalysts from industrial use.  These whole-
cell platforms are too slow to compete with the industrial processes with kcat/KM values ranging 
in the 10
-1
-10
1  
M
-1
s
-1 
far below the desired value range of 10
5
 M
-1
s
-1
, which is the threshold for 
most biocatalyst to compete with conventional industrial catalyst[13, 14].   
  
1.2.5. Single Enzyme Decarboxylation: Phenylacrylic Acid Decarboxylation 
 
 In order to solve some of the problems discussed, researchers isolated the phenylacrylic 
acid decarboxylases from these various species to characterize, study, and asses their suitability 
for industrial use[36].  From this effort emerged two distinct decarboxylase families: the PAD 
family that required no cofactors and the UbiD family which appears to utilize a FMN-binding 
domain, but still participates in non-oxidative decarboxylation.  Isolated enzymes typically 
exhibit higher average activity than whole-cell preparations and thus, may be better suited to 
industrial applications.  Phenylacrylic acid decarboxylases and UbiD decarboxylases have been 
isolated from a variety of sources, but the best studied examples are PAD from Bacillus 
amyloliquefaciens and FDC from A. niger and S. cerevisiae.  
1.3 The PAD Family of Enzymes 
 The PAD family of enzymes is involved in the breakdown of lignin[37].  Plant matter is a 
major component of many ruminant animal diets. The breakdown of plant matter results in a 
high concentration of two common compounds p-coumaric acid and ferulic acid which are toxic 
to many gut microbes[26, 33, 34, 38].  The mechanism by which these enzymes decarboxylate p-
hydroxyphenylacrylic acid derivatives (Figure1.3) was described for the PAD enzyme from 
Lactobacillus plantarum[31, 39, 40].  The first step of the catalytic mechanism is the abstraction 
of a proton from the phenolic group of p-coumaric acid by glutamate 71. Tautomerization to the 
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quinone form allows the β-carbon to abstract a proton from most likely water to form a p-
quinone methide intermediate.  In the second step, the p-quinone methide intermediate undergoes 
decarboxylation, liberating carbon dioxide and forming a vinylogous double bond[39, 40]. 
  
 
Phenolic acid decarboxylase from B. amyloliquefaciens was identified as a member of the 
PAD family of enzymes based on a sequence-based subgroup analysis. This involved using B. 
subtilis as a seed sequence for PSI-BLAST of which the top 250 were collected after the 10
th
 
iteration.  Multiple alignment sequences were performed and scored using a BLOSUM62 scoring 
matrix, the top 8 scoring corresponding proteins were chosen and expressed[41].  This analysis 
was designed to select enzymes to exhibit better decarboxylase activity over previously 
established PAD enzymes.  This approach identified 8 target sequences likely to have higher 
activity over previously described purified PAD enzyme.  The analysis identified PADs from B. 
amyloliquenfaciens, Bacillus coaglulans, Citrobacter sp., Lactobacillus fermentum, L. 
Figure 1.3  Proposed decarboxylation mechanism of PAD family members Lactobacillus plantarum[39,40]. 
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plantarum, Lactobacillus sakai, Pediococcus pentosaceus, and Streptomyces sviceus, which were 
chosen for study[30]. 
 B. amyloliquenfaciens PAD along with 7 other PAD sequences were cloned in E. coli  
BL21 DE3. Only 5 of the PAD sequences, BAPAD, PPPAD, LFPAD, LPPAD, and LSPAD, had 
activity.  BAPAD had the highest activity (366 µmol min
-1
 mg
-1
 enzyme) and was chosen for 
further characterization[30].  BAPAD was active in a pH range of 4.0-6.0 at 37 ºC with the pH 
optimum being 5.8.  BAPAD appeared to require no cofactor[30].  BAPAD catalyzed the 
decarboxylation of a range of phenylacrylic acids including p-coumaric acid, ferulic acid, and 
caffeic acid. However, BAPAD showed no activity for substrates without the p-hydroxy group 
such as m-coumaric acid, o-coumaric acid, and cinnamic acids, nor did it possess activity for 
substrates with additional methoxy groups in the two meta positions such as sinapinic acid.  
Steady-state kinetics of BAPAD showed a KM value of 0.7 mM pCA, a kcat value of 6000 s
-1
, and 
a kcat/KM value of 8.6x10
6
 M
-1
s
-1
.  These values are the highest reported values in the literature to 
date[30]. 
 BAPAD, like many previously described whole-cell systems, suffers from competitive 
product inhibition.  In aqueous systems, p-hydroxystyrene builds up, ultimately inhibiting 
BAPAD and lowering the yield of the reaction to 22.7%.  The Ki of BAPAD was determined to 
be 20 mM p-hydroxystyrene. In order to overcome product inhibition, water-immiscible organic 
solvents were employed to remove products from the reaction.  The highest conversion yield, 
88.4%, was achieved by using a biphasic system with 1-octanol as the organic phase.  BAPAD, 
to date, is the most catalytically efficient non-oxidative decarboxylase to date[30]. 
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1.4. The UbiD/UbiX and FDC1/PAD1 Decarboxylation System 
 
 The UbiD family was first identified and named after the E. coli UbiD protein, which is 
proposed to decarboxylate 3-octaprenyl-4-hydroxybenzoate, an intermediate in the biosynthesis 
pathway of ubiquinone in bacteria[19, 42-45].  UbiD-like enzymes and their corresponding 
UbiX-like counterparts have often been reported to act in tandem to facilitate various 
decarboxylation processes. UbiD homologs have also been determined to be part of an 
alternative biosynthetic pathway in cyanobacteria to produce menaquinone from 1,4-dihydroxy-
6-naphthoate[46]. The structure of UbiD from Pseudomonas aeruginosa has also recently been 
elucidated.  UbiD shares some distinct structural homology to a family of NADH:FMN 
oxidoreductases, as well as the flavin-dependent EpiD and MrsD cysteine decarboxylases[20, 
47]. The crystal structure of P. aeruginosa UbiD only showed magnesium bound to the enzyme, 
rather than a flavin.  The UbiD homolog FDC1 from S. cerevisiae exhibits a range of differences 
from UbiD including the location of metal ions, the location of the active sites, and its reported 
oligomerization state.  The UbiD family of proteins as a whole (Figure 1.4) exhibit a significant 
variation of substrate scope and previous studies indicate that members of the UbiD family form 
oligomers, either with other UbiD-like proteins or distinct subunits[18, 19]. 
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Members of the UbiD family catalyze a wide range of reversible decarboxylation reactions 
(Figure 1.4).  In nature, these enzymes are involved in a wide array of biochemical processes 
ranging from breaking down xenotoxins in S. cerevisiae and A. niger to being responsible for the 
decarboxylation of 3-octaprenyl-4-hydroxybenzate in the bacterial ubiquinone biosynthetic 
pathway.  Due to the lack of mechanistic characterization efforts concerning the UbiD family of 
enzymes, FDC from S.  cerevisiae is currently the best characterized due to its readily available 
substrates and its relative stability[48].   
 
Figure 1.4  Proposed phylogenic analysis of the proposed UbiD family of enzymes[48] 
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  1.5. In vivo Study of FDC1/PAD1 from Saccharomyces cerevisiae 
 
 Antimicrobial compounds such as phenylacrylic acid and sorbic acid are commonly 
incorporated into foodstuff to act as preservatives or flavor enhancers.  These antimicrobial 
compounds are also present in plant cell walls, which protect plants from invading fungi by 
lowering cytosolic pH[27, 33, 34, 38, 49].  Despite these efforts, numerous fungi evolved 
mechanisms to detoxify their environments of these xenotoxins[27, 34, 38, 40].  FDC1 and 
PAD1 are involved in the non-oxidative degradation of phenylacrylic and sorbic acids to styrene 
and 1,3-pentadiene respectively, conferring resistance to S. cerevisiae and A. niger.  FDC1 and 
PAD1 break down these antimicrobial compounds through decarboxylation to produce carbon 
dioxide and the vinylbenzene product[23, 24]. 
 Genetic manipulation experiments to breakdown these inhibitory compounds intially 
suggested that PAD1 was solely responsible for processing these inhibitory compounds.  
Deteling pad1 eliminated styrene and 1,3-pentadiene production in vivo, suggesting that PAD1 
was responsible for the decarboxylase activity observed in the wild type strains[24].  A separate 
study in which the fdc1 gene was introduced to sake yeast (a species that lacks the fdc1 gene) 
resulted in the development of resistance to ferulic acid, cinnamic acid, and sorbic acid, 
suggesting that FDC1 was requried for the degradation of phenylacrylic compounds[24].  
Genomic analysis of fdc1 and pad1 indicated that these two genes were located in close 
proximity to each other on chromosomes IV and VI in S. cerevisiae and A. niger 
respectively[24].  Knockout strains ∆fdc1, ∆pad1 and ∆fdc1/∆pad1 in S. cerevisiae were 
analyzed for decarboxylase activity against p-coumaric acid, trans-cinnamic acid, and ferulic 
acid. All three knockout strains lacked decarboxylase activity, indicating that both genes were 
required for decarboxylase activity.  Similar results were observed in A. niger.  This established 
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that FDC1 and PAD1 were both required for decarboxylase activity.  However, no biochemical 
studies were conducted to characterize the relationship between FDC1 and PAD1. 
   
1.6. Decarboxylation Mechanism 
 Historically, the decarboxylation mechanism by which the UbiX/UbiD or PAD1/FDC1 
systems broke down carboxylic acids to their vinyl products were generally considered to be 1 of 
3 possibilities.  Based on the crystal structure of UbiD from P. aeruginosa possessing an Mg
2+
 
[19, 24], a hypothesis was put forth indicating that this decarboxylase could perform a non-
oxidative, metal-dependent decarboxylation[50]. The crystal structure of UbiX resembled a 
flavin-dependent, non-oxidative cysteine decarboxylase, such as MrsD, therefore suggesting this 
enzyme may behave as a flavin-dependent decarboxylase[20, 47].  However, because neither 
enzyme had an established active site, there was also the alternative hypothesis that these 
enzymes catalyzed decarboxylation in a cofactor-independent manner. 
 However, as this thesis will detail later on, these hypothesized mechanisms were based 
on a fundamental misunderstanding of the relationship between the UbiD/UbiX enzyme families 
as well as the lack of knowledge regarding the existence of the prenylated flavin (PrFMN) that is 
required to perform the described non-oxidative decarboxylation[51-57]. 
1.6.1 Non-oxidative Metal Decarboxylation Mechanism 
 The published crystal structure of UbiD from P. aeruginosa possesses a magnesium ion 
[24], which could indicate that UbiD undergoes a non-oxidative metal-dependent 
decarboxylation.  One representative enzyme that performs this mechanism is ɑ-amino-β-
carboxymuconate-ɛ-semialdehyde decarboxylase (ACMSD), which is involved in the tryptophan 
metabolism[58].  ACMSD enzymes are a member of the aminohydrolase superfamily, which 
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mediates non-hydrolytic carbon bond cleavage.  The most analyzed ACMSD is from 
Pseudomonas fluorescens where the substrate enters the active site with its C2 carboxylate in 
close proximity to a zinc ion (Figure1.5)[11,58].  A conserved histidine residue mediates 
deprotonation of a water molecule coordinated to the zinc ion, creating a hydroxide.  The 
hydroxide attacks the β-carbon of the substrate to hydrolyze the enoic acid moiety.  Release of 
carbon dioxide occurs simultaneously with the elimination of the hydroxide, facilitated by the 
histidine[58, 59]. 
 
Figure 1.5 Metal dependent non-oxidative decarboxylation mechanism of ACMSD from P. fluorescens[58] 
1.6.2. Flavin-based Decarboxylation Mechanism 
 UbiX from P. aeruginosa was shown to bind FMN and is structurally homologous to 
MrsD and EpiD, which are FMN-dependent decarboxylases that are part of the 
phosphopantothenoylcysteine (PPC) decarboxylase family, commonly referred to as the 
cysteine-dependent decarboxylase family[20, 21, 47].  These enzymes require substrates to 
possess a cysteine group to facilitate decarboxylation, a chemical motif distinctly missing in the 
substrates of UbiD/UbiX and FDC1/PAD1.  MrsD, EpiD, and a PPC decarboxylase from 
Arabidopsis thaliana involved in coenzyme A biosynthesis, have shown that flavin-mediated 
decarboxylation occurs through the same general states (Figure 1.6)[59].  FMN facilitates the 
oxidation of the cysteine to generate a thioaldehyde intermediate along with formation of 
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FMNred[60, 61].  The generation of the thioaldehyde adduct promotes spontaneous 
decarboxylation through internal delocalization of the carbanion to the cysteinyl sulfur, which 
creates a double bond between the ɑ, β carbons and reconstitutes the thiol group.  In EpiD and 
MrsD this concludes turnover, but AtPPC decarboxylase continues the reaction by catalyzing the 
reduction of the C-C double bond using a proton donated by a conserved cysteine residue and the 
hydride stored on the flavin, returning the flavin to its oxidized form[59]. 
 
Figure 1.6  Flavin-dependent, non-oxidative cysteine decarboxylase mechanism of EpiD 
1.6.3. Cofactor-Independent Decarboxylation   
 The UbiD/UbiX decarboxylation system has been previously described as cofactor-
independent.  Cofactor-independent decarboxylase systems encompass a relatively small class of 
enzymes.  These include 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase 
(OHCUD) which is involved in oxidative ureide degradation during purine catabolism, and 
methylmalonyl-CoA decarboxylase (MMCD), a member of the crotonase family[62,59].  The 
decarboxylation occurs stepwise for both enzymes.  Three crystal structures of OHCUD in 
complex with a substrate analog, product, and inhibitor suggest that the proximal active site 
carboxylic acid side chain is responsible for destabilizing the substrate ground state through 
electrostatic repulsion to facilitate carbon dioxide release (Figure 1.7)[62, 63]. 
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A 
 
Figure 1.7  (A) OHCUD and (B) MMCD non-cofactor dependent decarboxylation mechanism 
 
One of the most studied cofactor-independent decarboxylases, orotidine 5’-
monophosphate decarboxylase (OMPCD), is involved in pyrimidine biosynthesis.  OMPCD is 
capable of increasing the non-enzymatic rate by a factor of 10
17
, making OMPCD one of the 
most proficient enzymes known[64].  Numerous studies have investigated the mechanism and 
have found that the negative charge of a proximal carboxylic amino acid destabilizes the 
substrate ground state through electrostatic repulsion, as accepted for OHUCD and MMCD.  The 
negative charge accumulating on the C6 is stabilized by a conserved lysine residue, which 
protonates the carbon concomitant with carbon dioxide release avoiding the high-energy 
carbanion transition state is generated (Figure 1.8).  The carbanion is stabilized through transfer 
of the negative charge to the carbonyl O4.  This is supported by interaction with a backbone 
amide, analogous to the MMDC[65,64]. 
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Figure 1.8  Non-oxidative decarboxylation mechanism of OMPCD 
 
1.7. UbiD/UbiX Decarboxylase System’s Pharmaceutical and Agriculture Relevance 
 
1.7.1. UbiD/UbiX as a Target for Antibiotics 
 
 Antibiotic drugs revolutionized medicine and made our modern way of life possible.  In 
addition to their essential clinical role, antibiotics play a role in an array of nonclinical 
applications including promoting livestock growth, preserving materials from contamination, and 
treating blight in agriculture.  The successful uses of these therapeutic agents are compromised 
by the development of resistance to these compounds by microbes over time[66, 67]. 
 Antibiotic resistance is an ever-increasing concern, due to the increase in drug-resistant 
bacteria coupled with the low rate of new antibiotic compounds being discovered.  Currently, 
there are more than 20,000 potential resistance genes of nearly 400 different types, based on 
bacterial genome sequences[66]. Most classes of antibiotics were discovered in the mid to late 
20
th
 century and are slowly losing their effect. Without additional research, it is likely that 
humanity could return to the pre-antibiotic era.  Given the importance of antibiotics to our way 
of life, as well as the growing apprehension surrounding the threat of resistance, scientists are 
studying every aspect of bacteria cell processes as well as the mechanisms behind antibiotic 
resistance to develop new antibiotics. 
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 There is interest in exploring the UbiD family of enzymes for its application in 
antimicrobial research[19].  Members of the UbiD family are found in many of the bacteria on 
the World Health Organization’s list of the most dangerous bacteria, including P. aeruginosa, 
Enterococcus faecium, and Staphylococcus aureus[19].  UbiD catalyzes the conversion of 3-
octaprenyl-4-hydroxybenzoate to 2-octaprenylphenol in the bacterial ubiquinone biosynthetic 
pathway[42].  Ubiquinone is essential to promote the growth of many bacteria due to its 
regulatory roles. For example, ubiquinone prevents the onset of anaerobic metabolism by 
interfering with the Arc two-component signal transduction system[68].  Also in E. coli, 
ubiquinone derivatives participate in disulfide bond formation by providing oxidizing power to 
the cytoplasmic membrane protein DsbB[68].  Deletion of the ubiD gene severely reduces 
ubiquinone levels (~75%) causing a severe retardation in growth rate.  However, this deletion by 
itself is not lethal as an alternative biosynthetic pathways are present in numerous bacteria[44].   
The unique ubiquinone machinery in bacteria opens the opportunity to selectively modulate the 
activity of UbiD to stress bacteria into a bacteriostatic state. Bacteriostatic agents limit the 
growth of bacteria, thus enabling the host's native defenses to kill bacteria.  Bacteriostatic agents 
are sometimes preferred over bactericidal agents as their slower mechanism of action avoids the 
build-up of endotoxins that produce toxic shock syndrome which currently kills over 200,000 
persons per year[69]. 
1.7.2. FDC1/PAD1 Decarboxylase as Agricultural Antifungal Target 
 
Invasive, life-threatening fungal infections are a major cause of morbidity and mortality, 
particularly for patients with compromised immune function.  Over the past 30 years, the number 
of immunocompromised individuals increased dramatically with the HIV epidemic as well as the 
increase in the incidence of cancer and practice of hematologic and solid organ 
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transplantation[70].  However, there are only three classes of antifungal drugs, two of which, 
azoles and polyenes, were introduced in clinics by 1980.  These drugs are rapidly becoming 
outdated as more fungal strains are becoming resistant to these classes of drug molecules.  
Therefore it’s rather sobering to consider that there is only one current class of antifungals, 
echinocandins, treat fungal infections[70]. 
Fungal infections have serious consequences. In wealthy countries, the 90-day survival 
following the diagnosis of candidemia varies between 55% and 70%, depending on the 
underlying condition of the patient.  The outcomes are even worse for aspergillosis despite the 
availability of voriconazole, a commonly prescribed antifungal (Figure 1.9)[71].  These 
outcomes are even worse in developing nations.  As immunosuppression therapies continue to 
develop in response to cancer and a host of autoimmune diseases so will the number of patients 
that may need antifungal therapies.  As the patient count rises, fungal treatments will inevitably 
become ineffective, thus prompting a need for novel antifungal treatment strategies[72]. 
 
Figure 1.9 Structure of voriconazole, a commonly prescribed antifungal agent 
 The challenge to developing novel antifungal drugs arises from the fact that fungal 
pathogens are closely related to the host.  Many fundamental biochemical and cell biological 
processes are conserved in fungi and humans[72].   Therefore, the challenge is identifying new 
lead molecules that disrupt processes unique to fungi.  Various fungi-exclusive processes are 
currently being investigated as targets including the biosynthesis pathways for 
glycosylphosphatidylinositol and β-1,6-glucan, both of which are important for fungal cell 
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walls[73]. Other essential processes of fungal growth and cell viability that are being 
investigated include poly(A)polymerase activity, translational elongation, cAMP homeostasis, 
and resistance mechanisms[72, 73].    
 The FDC1/PAD1 decarboxylation system functions as a resistance mechanism against 
antifungal compounds such as ferulic acid and sorbic acid[25].  Ferulic acid received attention as 
an antimicrobial compound as it was found to be one of the effective components in many 
Chinese herbal medicines derived from plants such as Angelica sinensis, Cimicifuga heraclifolia, 
and Lignsticum chuangxiong[33]. Among 5 commonly encountered fungi, including fungi that 
cause interior fungal infections, ferulic acid and other cinnamic acid derivatives inhibited growth 
with Ki values in the µM range, demonstrating their potentials as antifungal drugs. Fortunately, 
the biosynthetic pathway leading to the breakdown of ferulic acid in A. niger and associated 
fungal species appears to be unique, therefore combining an FDC1 inhibitor and cinnamic acid 
derivatives would provide a novel antifungal therapy[33, 34]. 
1.7.3. FDC1/PAD1 Decarboxylase as Agricultural Antifungal Target 
 
 The potential impact of fungal blights on food business or a country have been 
devastating, costing hundreds of millions of dollars and causing upwards of 5000 deaths[49]. 
Fungi such as Aspergillus flavus colonize maize and other agriculture products and release 
aflatoxin, a poisonous carcinogen.  Caffeic acid, ferulic acid, and vanillic acid inhibit the growth 
of these poisonous fungi by 60-100%.  However, these compounds have limited effectiveness as 
they eventually break down into vinyl guiacol, styrene, and other decarboxylated metabolites.  
Ferulic acid has a low toxicity to humans (LD50 = 2445 mg kg
-1
), making it an attractive food 
additive as a preservative[26].  However, ferulic acid and other antifungals, such as cinnamic 
acid, are broken down by PAD1/FDC1.  Understanding the mechanism of action of the 
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PAD1/FDC1 decarboxylation system would lead to an understanding on how toxic fungi are able 
to resist these antifungal compounds, which could lead to alternative and more effective 
strategies at improving food security and limiting the costs of fungi-related food damage[33]. 
 
1.8. Goals of this Work 
 
 
 The main objectives of this project are to initiate biochemical and biophysical 
characterization of FDC1/PAD1 decarboxylation system, to explain how these enzymes interact, 
explore the substrate range and mechanism of FDC1, and to isolate mechanistic intermediates of 
FDC1.  This project aims to provide a foundation for an understanding of the UbiD family and 
its relationship with the UbiX family.  This goal serves two purposes. The first is to provide a 
platform from which enzyme engineers can apply a combination of directed evolution and 
metabolic engineering to produce valuable commodity chemicals in a cost-efficient and 
sustainable manner.  The second benefit of this project is to provide some insight into how the 
UbiD family of enzymes work, thus providing a framework for the design novel antibiotics 
against bacterial and fungal species.  
 The research described in this thesis seeks to provide answers to these questions and 
others by exploring the mechanism of FDC1 and its relationship with PAD1.  First, in chapter 2, 
the relationship between PAD1 and FDC1 was investigated through a combination of genetic 
engineering, membrane dialysis experiments, and UV-visible spectroscopy.  The experiments 
show that PAD1 uses FMN to synthesize a novel, diffusible flavin cofactor that FDC1 uses to 
decarboxylate substrates.  Next, the mechanism of FDC1 was investigated using a combination 
of a Hammett analysis, solvent and secondary kinetic isotope effects, and NMR exchange 
experiments.  The secondary KIEs and Hammett analysis provided evidence that the rate-
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determining step of the reaction was the decomposition of the product-PrFMN adduct.  Finally, 
in chapter 4, the use of a substrate analog and potent inhibitor of FDC1, 2,2-
fluoronitrovinylbenzene, a 1,3-dipolar cycloadduct was trapped, definitively proving that FDC1 
employs a novel 1,3-dipolar cycloaddition mechanism to facilitate decarboxylation.  
Additionally, using bicarbonate to push the FDC1 equilibrium to favor the build-up of product-
PrFMN intermediates combined with MS
2
, PrFMN-styrene adducts were isolated.  Lastly, 
mutagenesis of FDC1 was used to explore the causes of the reported changes to the PrFMN 
cofactor spectrum, which appeared to be due to either a lack of cofactor or the build-up of a 
possible phenylaldehyde-PrFMN adduct. 
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Chapter 2 
 
Isofunctional Enzymes PAD1 and UbiX Catalyze the Formation of a Novel Cofactor       
Required by FDC1 and UbiD 
 
The work described in this chapter has been published as Lin, F., Ferguson, K. L., Boyer, 
D., Lin, X., Marsh E. N. G. M. PAD1 and UbiX are Isofunctional Enzymes Catalyzing the 
Formation of a Novel Cofactor Required by Ferulic Acid Decarboxylase (FDC) in Yeast and 4-
hydroxy-3-polyprenyl benzoic Acid Decarboxylase (UbiD) in Bacteria, ACS Chemical Biology, 
10, 1137-1144.  F. Lin constructed the relevant plasmids and performed and analyzed the results 
of the various dialysis assays. K.L. Ferguson & D. Boyer performed various kinetic assays and 
characterized the relevant gene products of the plasmids.  F. Lin, K.L. Ferguson, and E.N.G. 
Marsh wrote the paper.   
 
2.1 Introduction 
The UbiD/UbiX decarboxylation system has interest in the search for a renewable 
alternative to produce commodity chemicals and as a method to arrest the resistance mechanism 
of fungi to breakdown antifungal compounds such as, ferulic acid[24, 34, 72].   The members of 
the UbiD decarboxylate a wide variety of phenylacrylic acids including anti-oxidant molecules 
such as ferulic acid, and trans-cinnamic acid.  Enzyme-mediated decarboxylation is difficult 
because the transition state often involves is the build-up of negative charge on the ɑ carbon.   
Nature has therefore evolved a variety of decarboxylases which employ a wide variety of 
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catalytic strategies to facilitate decarboxylation using cofactors such as pyridoxine phosphate and 
thiamin pyrophosphate that serve as electron sinks and Lewis acidic metal ions[11, 50, 59, 74-
77].  The UbiD family of enzymes however, have long been referenced as requiring no cofactor 
required to do these aryl carboxylic acid decarboxylations. 
Unfortunately, the presumed substrate for UbiX and UbiD, 4-hydroxy-3-
octaprenylbenzoic acid, is commercially unavailable and requires an involved synthesis to 
synthesize. Genetic analysis established that UbiD and UbiX have two analogs in S. cerevisiae, 
FDC1 and PAD1[20, 23, 78].  Sequence comparison of these enzyme species suggests that there 
is a flavin binding domain in both FDC1/UbiD and PAD1/UbiX however, the role of this redox 
cofactor remains unexplained in the decarboxylation of phenyl acrylic acids and 4-hydroxy-3-
octaprenylbenzoic acid. (Figure 2.1) 
 
Figure 2.1  Decarboxylation of octaperenylphenolbenzoic acid by UbiD/UbiX and phenylacrylic acids by PAD1/FDC1 
This chapter describes a series of characterization experiments for FDC1, PAD1, and 
FDC1 co-expressed with PAD1.  FDC1 and PAD1 were overexpressed and purified from E. coli. 
PAD1 was determined to be a FMN containing protein, and is shown not to be a decarboxylase.  
Rather, PAD1 is shown to catalyze the formation of a novel diffusible cofactor, later found to be 
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PrFMN.  The E. coli UbiX and UbiD are related by sequence to PAD1 and FDC1 respectively 
and are involved in the decarboxylation of 4-hydroxy-3-octaprenylbenzoic acid, an intermediate in 
ubiquinone biosynthesis.  UbiX was found to also activate FDC1, suggesting that PrFMN plays a 
larger role in metabolism.  Once holo-FDC1 was made by co-expressing PAD1 with FDC1 this 
resulted in significant increase in the activity of FDC1 over previously identified kinetic 
constants. 
2.2 Materials & Methods 
2.2.1 Materials 
Trans-Cinnamic acid, para Coumaric Acid, Ferulic Acid, Ethyl acetate, Imidazole, 
Glycerol, THP, and FMN were all purchased from the Sigma Chemical company and were a 
biochemical grade, or HPLC reagent grade. 
 
2.2.2 Construction of the FDC1 Expression Vector 
A derivative of E. coli BL21 in which the ubiX gene was deleted by P1 phage 
transduction as previously described. The P1 phage lysate was prepared from the Keio single 
gene knockout strain of ∆ubiX: kan and used to transduce the ubiX knockout gene into E. coli 
BL21 Star (DE3) to obtain a strain designated E. coli BL21/∆ubiX 
 The genes encoding FDC1 (YDR539W) from S. cerevisiae was synthesized 
commercially by GenScript U.S.A. Inc. (Piscataway, NJ, USA) and codon-optimized for 
expression in E. coli. FDC1 was then subcloned into the expression vector pET-28b utilizing the 
NdeI and the BamHI restriction sites to generate pFDC.  pFDC introduced a vector-encoded N-
terminal 6 histidine-tag to facilitate enzyme purification. 
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2.2.3 Construction of sctPAD1 Expression Vector 
A derivative of E. coli BL21 in which the ubiX gene was deleted by P1 phage 
transduction as previously described[79].  The P1 phage lysate was prepared from the Keio 
single gene knockout strain of ∆ubiX: kan and used to transduce the ubiX knockout gene into E. 
coli BL21 Star (DE3) to obtain a strain designated E. coli BL21/∆ubiX 
 The genes encoding PAD1 (YDR538W) from S. cerevisiae was synthesized 
commercially by GenScript U.S.A. Inc. (Piscataway, NJ, USA) and codon-optimized for 
expression in E. coli. PAD1 was then subcloned into the expression vector pET-28b utilizing the 
NdeI and the BamHI restriction sites to generate pPAD1.  The pPAD1 plasmid has a vector-
encoded N-terminal 6 histidine-tag to facilitate enzyme purification. 
 A truncated gene was constructed by PCR to delete the N-terminal mitochondrial 
targeting peptide sequence (residues 1-58) using the following oligonucleotides as the forward 
(5’-ATTCCATGGCAAACGTATTGTGGTTGCGAT-3’) and reverse primer (5’-
AGTGGATCCTTATTTTTGCGAT-3’) using Ppad1 as the template sequence. After 
amplification, the PCR product was digested with NcoI and BamHI. The resulting plasmid, 
ptPAD1 no his lacks an N-terminal His tag.  
 
2.2.4. Co-expression of scFDC1 and tPAD1 and the Purification of scFDC1 
 The co-expression of tpad1 and fdc1 the two genes were introduced in tandem 
into pET28b and expressed from a single vector encoded promoter.  The tpad1 gene was 
amplified by PCR using the forward primer (5’-
ATTCCATGGGCAAACGTATTGTGGTTGCGAT-3’) and reverse primer (5’-
AGTGGATCCTTATTTTGATTTGATACCTTCCC-3’) using Ppad1 as the template.  After 
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amplification, the PCR product was digested with NcoI and BamHI and ligated with PEt28bb 
linearized with NcoI and BamHI.  The resulting plasmid, ptPAD1 no-His lacks an encoded N-
terminal His tag.  The fdc1 gene was introduced behind the tpad1 gene, and the stop codon 
deleted to allow for the incorporation of a C-terminal vector encoded six-histidine tag.  This 
genetic construct was accomplished by PCR using the forward primer (5’-
ATTGAGCTCAAGTATAAGAAGGAGATATATCATGCGCAAACTGAACCCGG-3’) which 
introduced a ribosome binding sequence, and the reverse primer (5’-
AATGTCGACTTTGTAACCGTAGCGTTTCCAGTTTTCATT-3’) and using Pfdc as the 
template.  The PCR product was digested with SacI and SalI and ligated with ptPAD1nohis cut 
with Sac1 and Sal1 to produce ptPAD1_FDC1, which was transformed into E. coli BL21 (DE3) 
to co-express both tpad1 and fdc1 genes. 
 
2.2.5. Assay of Styrene by Gas Chromatography  
  Assays of FDC1 activity were carried out in PBS buffer, pH 8.0 with a total 
volume of 500 µL using a saturating concentration of cinnamic acid, 6.7 mM, as the substrate; 
the concentration of FDC was typically 1.0 µM.  Assays utilizing tPAD1 typically included this 
enzyme at 10 µM concentrations.  The assay mixtures were incubated at 32 ºC for varying 
lengths of time. After which the products of the reaction were extracted by the addition of 500 
µL of EtOAc and the concentration of styrene was determined by GC-MS 
The GC-MS analysis was performed using a Shimadzu QP-2010S GC0MS instrument 
equipped with a quadrupole mass detector and a BD-5 column (Restek, 30m x 0.25mm x 
0.25µm).  The flow rate of the helium carrier gas is constant at 1 mL/min, and the inlet 
temperature was maintained at 200 ºC.  The interface temperature was maintained at 250 ºC.  
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Injections (10 µL) of EtOAc was held initially at 40 ºC for 3.5 minutes and then gradually 
increased to 90 ºC at 14 ºC/min then gradually increased from 90 ºC to 315 ºC at a rate of 20 
ºC/min, and then finally maintained at 315 ºC for 1 min. Chromatographic data were analyzed by 
GC-MS PostRun analysis software.  Enzymatic conversion of the cinnamic acid to styrene was 
quantified using a calibration plot of styrene standards of known concentration. 
 
2.2.6. Determination of the U.V.-Visible of Holo-FDC1 
 High activity preparations of FDC1, that is, enzyme prepared from E. coli strains co-
expressing tPAD1 and FDC1, were examined using an 8543 Hewlett Packard spectrophotometer.  
A typical spectrum included 80 µM FDC1 in a 100 mM pH 7 sodium phosphate buffer at room 
temperature.  The data was acquired using the Olis Works UV-Vis spectrum software. 
 
2.2.7. Determination of Steady-State kinetic constants of FDC1 
The activity of FDC was determined with 8543 Hewlett Packard spectrophotometer.  
High activity preparations of FDC that is, enzyme prepared from E. coli strains co-expressing 
tPAD1, the decarboxylation of substrates could be followed by the decrease in absorbance of the 
UV-active substrates.   Typical assays were performed in 100 mM potassium phosphate buffer, 
pH 7.0, at room temperature (RT) and contained 200-500 nM FDC.  The substrate concentration 
ranged between 0.05 -1.5 mM; at higher concentrations, the absorbance of the substrate became 
too high.  Decarboxylase activity was followed by monitoring the decrease in absorbance at 304 
nm for cinnamic acid ɛº = 1140 M-1 cm-1; 334 nm for para-coumaric acid ɛº = 988 M-1 cm-1; and 
344 nm for derelict acid ɛº = 1330 M-1 cm-1.  Velocity data (equation 1) were fitted to the 
Michaelis-Menten equation (2) using Origin Software. 
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Equation 1                                                                                       specfic activity  =
 (
𝑑𝐴
𝑑𝑡 )
ɛ𝑤𝑎𝑣𝑒𝑙𝑒𝑛𝑔𝑡ℎ ∗ [𝐸]
 
Equation 2                                                                                                                           𝑣 =  
𝑘𝑐𝑎𝑡[𝑆][𝐸]
𝐾𝑀 + [𝑆]
   
 
2.2.8.  LC-MS of Denatured scFDC1 
The molecular weights of the FDC1 and tPAD1 proteins and their associated small 
molecules were determined using an Agilent 6520 LC-accurate-mass Q-TOF MS system.  The 
protein was passed through a PD-10 desalting column (GE Healthcare) and acidified with 0.1% 
formic acid.  Samples ( 5 µL) were injected onto a Poroshell 300SB-C8 column equilibrated with 
0.1% formic acid and 5% acetonitrile.  Proteins were eluted for 5 min with 95% water: 5% 
acetonitrile followed by an increasing gradient of acetonitrile to 100% over the course of 7 min 
at a flow rate of 0.5 mL/min.  Eluting proteins were detected at 280 nm.  Mass data were 
obtained using intact protein mode and analyzed using Agilent MassHunter Qualitative Analysis 
software.  The raw data was deconvoluted concerning maximum entropy.  For small molecule 
analysis, proteins were precipitated with an equal volume of 1:1 dichloromethane/methanol in 
glass tubes and the organic solvent removed under a stream of dry nitrogen.  The sample (20 µL) 
then was injected onto a Zorbax 300SB-C18 column equilibrated with 0.1% formic acid and 5% 
acetonitrile, followed by a 2 min washing with 95% water/5% acetonitrile.  Then, the gradient of 
acetonitrile was increased to 100% over 10 min at a flow rate of 0.4 mL/min.  Mass data were 
obtained using small molecular mode and analyzed using Agilent Mass Hunter Qualitative 
Analysis software.  Automatic MS
2
 acquisition obtained MS/MS data.  A continuous scan event 
consisting of one full MS scan (50-2000 m/z) followed by three data-dependent MS
2
 were 
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carried out.  The three most intense ions from the initial MS scan were selected individually for 
collision-induced dissociation at 50 eV 
 
2.3 Results 
  2.3.1.  Properties of S. cerevisiae FDC1 Recombinantly Expressed in E. coli 
FDC containing an N-terminal 6-histidine tag was successfully overexpressed in E. coli. 
BL21, homogenized and purified by standard methods using a nickel-NTA column (Figure 2.2). 
The molecular weight of the FDC1 determined by LC-ESI-MS was 57898.15 Daltons, which is 
in excellent agreement with the predicted mass of 57897.8 Daltons (Protein mass calculator).  
Analysis of FDC1 by native gel electrophoresis (Figure 2.2) indicated that the protein migrated 
with an apparent molecular weight of ~480 kDa suggesting that FDC1 adopts an oligomeric 
structure in solution.  Interestingly, FDC1 purified from E. coli exhibited activity in the absence 
Figure 2.2.  Purification and initial characterization of FDC. (A) SDS-PAGE and native PAGE analysis of purified FDC.  (B) 
LC-ESI-MS analysis of purified FDC. (C) pH dependence of FDC1 decarboxylase yield 
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of its genetic partner PAD1, which is consistent with previous studies that found styrene 
produced from engineered E. coli cells did not require the introduction of the PAD1 gene.  The 
enzyme activity of the PAD1/FDC1 dual enzyme system was optimal between pH 7.0 and 8.0 
(Figure 2.2.). 
The specific activity of the dual enzyme assay determined by GC-MS was found to be 
0.54 µM styrene min
-1
 mg
-1
 enzyme.  Unexpectedly, it was found that dialyzing FDC1 against 
phosphate buffer (membrane cutoff =3.5 kDa) for 24 hrs resulted in the almost complete loss of 
activity (Figure 2.3), suggesting that FDC1 activity required a low molecular weight cofactor for 
activity.  Consistent with this, the addition of a cell-free lysate of E. coli BL21 was able to 
completely rescue activity. (Figure 2.3) However, FDC1 was unable to be reconstituted if the   
cell-free lysate was first dialyzed against buffer through a 3.5 kDa cutoff membrane.  Attempts 
to activate FDC using common commercial biochemical cofactors such as thiamine 
Figure 2.3. Effect of dialysis and addition of E. coli BL21 cell lysate on FDC1 activity.  The activity of FDC1 
as purified from E. coli BL21 is arbitrarily assigned as 100% and corresponds to specific activity of 0.54 
µmol styrene*min-1mg-1enzyme 
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pyrophosphate, pyridoxal phosphate, nucleotides, NADH, NADPH, FMN, and FAD and various 
metal ions were unsuccessful. 
 
2.3.2. E. coli UbiX is isofunctional with PAD1  
Both FDC1 and PAD1 are reported to be essential for the decarboxylation of 
phenylacrylic acid in vivo in S. cerevisiae; therefore, it was considered whether the homologous 
E. coli protein, UbiX, was a substitute for the function of PAD1 in E. coli.  To study this, the 
ubix gene was removed in E. coli BL21 to create an E. coli BL21/∆ubix knockout strain.  
Expression and purification of FDC1 from the ∆ubix strain resulted in protein completely lacking 
in decarboxylase activity, and cell lysates prepared from this strain were unable to reactivate 
dialyzed FDC1.  However, the inactive enzyme could be activated from lysates prepared from 
either wild-type E. coli BL21 or by lysates prepared from E. coli BL21/∆ubix when purified 
PAD1 (lacking the N-terminal mitochondrial targeting sequence) was also added.  These 
observations suggested that PAD1 and UbiX might function to synthesize a low molecular 
weight cofactor necessary for the activity of FDC1[24, 42].  
 
2.3.3. Expression and Characterization of tPAD1 in E. coli. 
Initial attempts to express the full-length PAD1 in E. coli resulted in poor levels of 
expression and the recombinant protein lacked the expected FMN cofactor.  However, deletion 
of the first 58 residues, which appear to encode a mitochondrial targeting sequence, resulted in 
the expression of a soluble protein that could be purified by standard methods, utilizing N-
terminal encoded 6-His tag affinity chromatography on a nickel-NTA column (Figure 2.4). The 
truncated form of PAD1 is designated tPAD1.  The molecular weight of the protein determined 
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by LC-ESI-MS was 21808.6 Da (Figure 2.4).  In excellent agreement with the predicted 
molecular weight of 21808.4 Da.  The molecular weight of the protein was estimated as ~300 
kDa by gel filtration chromatography, indicating that tPAD1 was an oligomeric protein solution. 
Purified tPAD1 was yellow, and the UV-Vis spectrum exhibited maxima at 384 and 458 
nm, characteristics of a protein with oxidized FMN bound to the protein.  FMN was confirmed to 
be bound to the protein by LC-ESI-MS (Figure 2.4). Interesting, the absorption maximum at 385 
nm is more intense than that at 458 nm, (Figure 2.4) whereas for FMNOX the opposite is true.  
This experiment suggested that tPAD1 may contain another chromophore, although LC-ESI-MS 
identified no other known chromophore.  tPAD1 was unable to catalyze the conversion of the 
TCA to styrene by itself. This demonstrated that contrary to initial genetic analyses, and shows 
the tPAD1 enzyme is not an isofunctional enzyme with FDC1. 
Figure 2.4 Purification and initial characterization of PAD1.  (A) SDS-PAGE analysis of purified tPAD1. (B) ESI-MS of puri-
fied tPAD1.  (C) UV-visible spectrum of tPAD1 indicative of bound flavin cofactor(s).  LS-MS of flavin cofactor isolated 
from tPAD1, demonstrating, the protein contains FMN. 
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The crystal structures of E. coli O157: H7 Pad1p and P. aeroginosa UbiX have been 
determined, revealing them to be dodecameric proteins containing FMN[20].  This is consistent 
with our characterization of PAD1 as an FMN-containing protein that exists as large oligomers 
in solution and suggests a common structure and function for these proteins.  Interestingly, 
Pad1p and UbiX are structurally related to the family of flavin-dependent peptidyl cysteine 
decarboxylates.  These include EpiD and MrsD, for which structures have been determined, that 
are involved in the biosynthesis of the lantibiotic peptides and mersacidin, respectively, and Dpf 
that catalyzes the decarboxylation of 4’-phosphate-N-pantothenol cysteine to 4’-phosphate-N-
pantethine in coenzyme A biosynthesis[47,59].  However, there is currently no evidence to 
support either Pad1p or Pad1 functions as cysteine decarboxylases.  Instead, as discussed below, 
our results suggest these enzymes are more likely involved in catalyzing the formation of a 
modified form of FMN. 
 
2.3.4.  Role of tPAD1 in the Activation of FDC1 
 An experiment was performed to examine whether direct interaction between 
FDC1 and PAD1 is necessary for the activation of FDC1.  A dialysis cell was set up in which 1 
µM apo-FDC1 was introduced on one side of a 3.5 kDa cutoff dialysis membrane in a buffer 
containing 6.7 mM cinnamic acid.  On the other side of the membrane purified tPAD1 and cell 
lysate, or just E. coli BL21 DE3 cell lysate or BL21 DE3 star ∆ubiX cell lysate was introduced 
on one side of a 3.5 kDa membrane.  At various times, the reaction was analyzed for the        
production of styrene by GC-MS (Figure 2.5).  Whereas E. coli ∆ubiX cell lysate was unable to   
activate FDC1, the addition of 10 µM purified tPAD1 to the lysate resulted in the activation of 
FDC1, indicating that tPAD1 catalyzes the conversion of a small molecule in the cell lysate to 
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the cofactor for FDC1.  Interestingly, the experiment, purified tPAD1 alone was effective at 
activating FDC1 in the absence of cell lysate, suggesting that during purification some of the 
cofactors remained bound and subsequently diffused from the enzyme.  The activation of FDC1 
is not due to FMN diffusing from tPAD1, as FMN itself doesn’t activate FDC1.  We were not 
able to detect the presence of the cofactor by LC-ESI-MS in samples of tPAD1.  The reason for 
this is unclear.  It is possible that this reflects the low occupancy of the cofactor in the active site 
of tPAD1, as a high concentration of tPAD1 relative to FDC was used in the dialysis experiment. 
 
2.3.5. Initial characterization of the FDC1 cofactor 
The experiments described suggested that only a small fraction of FDC1 isolated from E. coli 
BL21 contained the cofactor.  Therefore, we attempted to increase the occupancy of FDC by co-
expressing FDC1 with tPAD1 lacking a His tag in E. coli BL21 cells.  The specific activity of 
FDC1 purified from these enzymes was much higher: 292.4 µM styrene/(min
-1
*mg
-1
) enzyme 
which was 8 fold higher than that of preparations of FDC1 from E. coli lacking tPAD1.  
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Figure 2.5 Styrene yield by a dialysis experiment where apo-FDC1 was incubated with tPAD1, BL21 DE3 cell lysate, ∆UbiX 
cell lysate and ∆UbiX cell lysate + tPAD1 
  
38 
 
Furthermore, the increased cofactor content resulted in an enzyme preparation that was visibly a 
pale-yellow color.  The UV-Visible spectrum of the FDC1-bound chromophore exhibited an     
absorbance maximum at 342 nm characteristic of a reduced flavin (Figure 2.5)[80, 81].  
However, whereas reduced flavins are readily reoxidized under the aerobic condition in which 
the protein was handled, the chromophore associated with FDC1 was stable, and its spectrum 
remained unchanged when it was released from the protein preparation by denaturation with 1:1 
dichloromethane/methanol.  A preparation of the cofactor, obtained by precipitation of the 
protein with 1:1 dichloromethane/methanol, followed by removal of the organic solvent was 
capable of activating apo FDC1; thereby confirming that the pale-yellow chromophore 
associated with FDC1 is indeed responsible for the activity of the enzyme.  
The protein-free cofactor was further subjected to LC-ESI-MS
2
 analysis.  The major 
species in the primary MS spectrum (Figure 2.6) was characterized a (M+H) 
+
/z = 661.22 and 
Figure 2.6 U.V.-visible spectrum of holo-FDC1.  The spectrum is suggestive of a reduced flavin-like chromophore 
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(M+H)
+
/z = 625.2054 that probably represents the loss of one and two water molecules 
respectively from the parent ion.  From this, a molecular weight of the cofactor was hypothesized 
to be 660.2212.  The experimentally determined weight, together with the intensity of the natural 
abundance
 13
C peak, is consistent with a molecule possessing between 27-32 carbon atoms.  I 
cautiously note that I cannot definitively rule out, given its labile nature, that this species might 
represent a fragment of the cofactor.  The major species was subjected to mass fragmentation and 
attempts were made to match the resulting MS
2
 data with various databases of small molecules 
including Chemical Entities of Biological Interest (ChEBI) metabolomics database, SciFinder 
(Chemical Abstracts Service) database, and the METLIN metabolomics database[82].  However, 
no convincing matches to compounds in these databases were found.  Further attempts to 
determine the identity of the FDC1 cofactor were hindered by the small amounts of material 
available and the instability of the molecule, which appears to react upon release from the 
enzyme.  Although the cofactor retained remained intact under the mildly acid conditions used in 
the LC analysis (0.1% formic acid), more strongly acidic (0.1 M HCl for 1 hr) or basic (0.1 M 
NaOH for 1 hr) conditions followed by neutralization, resulted in the disappearence of the 
cofactor.  LC-MS analysis of acid-treated samples revealed a complex mixture of products that 
could not be interpreted.  However, LC-MS analysis of base-treated samples revealed, among 
other fragments, the presence of a peak with (M+H)
 +
/z = 457.1 Da corresponding to FMN, 
providing further evidence that the cofactor comprises a modified form of FMN. 
  
40 
 
 
 Interestingly, the structures of E. coli UbiD, a homologous enzyme to FDC1, and 
an UbiD-like protein from P. aeruginosa have been solved; however, no cofactors are present in 
the crystal structure.  Although the E. coli enzyme is a hexamer whereas the P. aeruginosa 
enzyme is dimeric, they adopt very similar tertiary structures, and it is likely that FDC adopts a 
similar tertiary structure[18, 19].  The UbiD enzymes comprise three domains, and it is 
particularly intriguing that the central domain possesses a split β-barrel fold characteristic of 
flavin reductases. The structures reveal a large cleft in the putative FMN or a modified FMN 
Figure 2.7  High resolution of ESI-MS spectrum of the novel cofactor for FDC. (B)  High resolution ESI-MS of the highest mo-
lecular weight peak with (m+1)/z = 661.2279 
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derivative.  I speculate that under the conditions used to express these enzymes for 
crystallographic analysis, endogenous UbiX could not synthesize sufficient cofactor to saturate 
UbiD or that the cofactor may be lost or degraded during purification.  The unavailability of the 
native substrate of these bacterial enzymes, 4-hydroxy-3-octaprenylbenzoic acid, prevented their 
assay too determine whether these enzymes were indeed active enzymes. 
 Based on the U.V.-visible spectrum and its molecular weight, together with the 
fact that PAD1 contains FMN and that FDC1 resembles other flavin-binding enzymes, I propose 
that the novel cofactor is likely a modified form of reduced FMN.  The fact that the cofactor can 
be stable to air suggests that it is modified at N5, as alkylation on nitrogen would stabilize the 
reduced flavin ring against oxidation.  It was later revealed that the structure of the cofactor that 
involves is a reduced prenylated flavin, which would result in this new cofactor having a 
significantly larger mass than FMN, the cofactor would be oxygen stable, and would have 
spectral characteristics reticent of reduced FMN.  
 
2.3.6. Steady state kinetic properties of FDC1 
 The significant improvement in the activity of FDC1 resulting from its                  
co-expression with tPAD1 allowed the decarboxylation of ferulic acid to be followed 
spectrophotometer geometrically by the decrease in absorbance at 304 nm.  Although this limited 
the upper concentration range of substrate that could be studied before the substrate absorbance 
became too high, this assay, being far less cumbersome than the GC-MS-based assay, made is 
feasible to determine cat and KM for cinnamic acid and the structurally related compounds ferulic 
acid (trans-(4-hydroxy-3-methoxyphenyl)-acrylic acid and p-coumaric acid (trans-(4-
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hydroxyphenyl)-acrylic acid).  The kinetic constants for these substrates, at pH 7.0 and 25 ºC in 
100 mM potassium phosphate buffer, are given in table 1.  
Table 2.1  Steady State Kinetic Parameters for FDC1 
 
akcat [65] values were calculated based on the concentration of FDC protein.  As discussed in the text the true kcat is likely 
significantly higher due to incomplete cofactor occupancy 
 
 
Substrate 
 
kcat [65] (s
-1
) 
 
KM (µM) 
  
     kcat /KM (s
-1
M
-1
) 
 
 
trans-Cinnamic Acid 
 
4.6 ± 0.2 
 
180 ± 24 
  
25500 ± 3500 
 
 
trans-Ferulic Acid 
 
3.8 ± 0.3 
 
180 ± 41 
  
21000 ± 4500 
 
 
trans-Coumaric Acid 
 
1.5 ± 0.1 
 
110 ± 26 
  
13600 ± 880 
 
Figure 2.8  Michaelis-Menten plot of trans-cinnamic acid.   
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Figure 2.9  Representative FDC1 assay invoving the decarboxylation of ferulic acid monitored at 346nm 
 
Trans-cinnamic acid proved to be the most active substrate, additionally FDC1 
decarboxylated additional phenylacrylic acid substrates including ferulic and coumaric acids, 
only slightly less efficiently.  FDC1’s ability to decarboxylate a wide variety of substrates 
suggests that it may be active with a wider range of substituted phenyl acrylic acid derivatives, 
which may lend it to industrial uses.  Although co-expression of FDC1 with tPAD1 results in a 
large increase in enzyme activity, it appears that the cofactor occupancy is still low if the 
extinction coefficient for the FDC1 cofactor is similar to reduced FMN.  Therefore, the true kcat 
values for FDC1 acting on these substrates may be higher than the values reported here. 
 I note that ferulic acid decarboxylases, also described as phenolic acid 
decarboxylates, have been described from a wide variety of species including, Pseudomonas 
flourscences and B. subtillis.  However, these enzymes require no organic cofactors and are 
dimers of subunit Mr = 20 kDa.  They catalyze the decarboxylation of phenolic acids, such as 
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coumaric and ferulic acids, through a mechanism involving deprotonation of the phenolic group 
which is required to generate a quinone intermediate.  However, they do not catalyze the 
decarboxylation of cinnamic acid, in which the phenyl ring is inactivated.  The two classes of 
FDC enzymes are therefore mechanistically quite distinct from each other[30]. 
 
2.4 Conclusions 
 The function of PAD1 and FDC1 as enzymes involved in the detoxification of 
aromatic carboxylic acids was first elucidated through genetic analysis of yeast mutants deficient 
in the metabolism of cinnamic acids and its derivatives[24].  Homologues of these genes are 
present in a range of other microbes including bacteria and some fungi.  Although sequence 
similarities with better-characterized enzymes from other organisms allowed some predictions as 
to the structure and cofactor requirements of these enzymes to be made, the function of PAD1, 
which is widely distributed in microbes, is to make a PrFMN cofactor.  Members of the UbiD 
family of enzymes utilize PrFMN to facilitate aromatic decarboxylation[48, 54, 57, 83-86].  E. 
coli strains solely overexpressing PAD1 genes, and homologs of PAD1 are unable to 
decarboxylate phenyl acrylic acid derivatives from the enterohemorrhagic E. coli strain O157: 
H7 bacteria strain, which exhibits no decarboxylase activity with a variety of phenyl acrylic acid 
derivatives.  These observations make it apparent that PAD1 is miss-named as it’s not a 
phenylacrylic acid decarboxylase; however, PAD1 transfers a DMAPP molecule onto reduced 
FMN to make reduced PrFMN that is up taken by FDC1 and oxidized[48, 54, 57, 83-86].  
The experiments reported here constituted the first time PAD1 and FDC1 were 
biochemically characterized, with the functions of PAD1 and FDC1 elucidated.  PAD1 
synthesizes a novel cofactor required by FDC1 for decarboxylase activity.  The liability of the 
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cofactor thus far has prevented the immediate identification of the cofactor; however, based on 
its UV-visible spectrum, its molecular weight, and the resemblance of PAD1 and FDC1 to other 
flavin-binding enzymes, I propose that the cofactor is likely a new, modified form of reduced 
FMN.  These initial results were confirmed when FDC1 from A. niger were crystallized with 
newly elucidated cofactor PrFMN.  The mechanism by the cofactor facilitates the 
decarboxylation of cinnamic acid was proposed to involve a novel 1,3 dipolar cycloaddition 
mechanism, as this type of decarboxylation reaction lacked any obvious precedent in flavin-
protein chemistry[60, 79-81, 87]. 
PAD1 and FDC1 share sequence similarities with the E. coli enzymes UbiX and UbiD, 
which are involved in the decarboxylation of 4-hydroxy-3-octaprenylbenzoic acid, an early step 
ubiquinone biosynthesis.  The experiments above show that UbiX can replace PAD1 in 
activating FDC1 and it was previously shown that PAD1 restores ubiquinone biosynthesis in a 
∆ubiX E. coli strain.  Therefore, UbiX and PAD1 appear to be isofunctional enzymes.  The 
evidence strongly implies that UbiD is, in fact, the 4-hydroxy-3-octaprenylbenzoic acid 
decarboxylase and that it uses the same cofactor as FDC1.  The existence of Pad1p, distinct from 
UbiX, in some E. coli strains, is intriguing as it suggests there are a variety of roles for PrFMN. 
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Chapter 3 
 
Uncovering the Mechanism of FDC1 through a Linear Free Energy 
 
Analysis, and Solvent and Secondary Isotope Effects 
 
The work described in this chapter has been published as Ferguson, KL., 
Arunrattanamook, N., Marsh, E. N. G. (2016) Mechanism of the Novel Prenylated Flavin-
Containing Enzyme Ferulic Acid Decarboxylase Probed by Isotope Effects and Linear Free-
Energy Relationship. Biochemistry, 55, 2857-2863. N. Arunrattanamook and K.L. Ferguson 
collaborated on the Hammett Analysis. K.L. Ferguson performed and analyzed the entirety of the 
isotope effect experiments.  K.L. Ferguson synthesized and analyzed the isotopically labeled 
singly labeled deuterated cinnamic acid.  K.L. Ferguson performed and analyzed the results of 
the NMR deuterium exchange experiment. K.L. Ferguson, N. Arunrattanamook, E.N.G. Marsh 
wrote the paper. 
 
3.1 Introduction 
 
 UbiX and UbiD family of enzymatic decarboxylase attracted interest for their potential 
industrial application to produce high value, optically pure chemicals under mild conditions in 
environmentally friendly bioprocesses and their potential as an antifungal and antibiotic 
Figure 3.1  Synthesis of PrFMN by PAD1 
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formulation.  Recent studies on FDC1 and UbiD enzymes established the presence of a new 
flavin derived cofactor, prenylated Flavin, and that these PrFMN decarboxylases decarboxylate  
β, γ-unsaturated carboxylic acids through a unique 1,3 dipolar cycloaddition mechanism.  
 The ubiX and ubiD and the related pad1 and fdc1 genes have been shown to encode 
proteins responsible for non-oxidative reversible decarboxylation of aromatic substrates.  These 
genes are widely distributed in archaea, yeast, and fungal genomes as means to breakdown 
xenotoxins whereas Ubix and UbiD play a key role in the prokaryotic ubiquinone biosynthetic 
pathway.  The genomic analysis led to the suggestion that ubiX and ubiD and the related pad1 
and fdc1 genes encode redundant decarboxylases. However the last chapter provided evidence 
that these enzymes do not encode redundant decarboxylases, but instead, UbiX and Pad1 are 
responsible for synthesizing PrFMN (Figure 3.1).  Recent crystal structures of PAD1reveals how 
DMAP and oxidized FMN bind; a crystal structure of E49Q mutant was able to trap an 
intermediate which DMAP reacted with reduced FMN.  The reaction ultimately results in 
reduced PrFMN although the mechanism by which the reduced PrFMN oxidizes to form the 
imminium form of the cofactor whether enzymatic or spontaneous remains uncertain.  FDC and 
UbiD both utilize the imminium form of the cofactor to facilitate the decarboxylation a range of 
aromatic carboxylic acids[51, 88]. Crystal structures of A. niger, S. cerevisiae, and Candida 
dubliniensis revealed various PrFMN cofactor species including the ketamine form, 
hydroxylated imminium PrFMN and oxidized imminium PrFMN. To observe which of these 
species is the active cofactor, and to gain insights into the catalytic mechanism, A. niger FDC1 
crystals were soaked with a range of trans-cinnamic acid derivatives and related compounds.  
Phenylpyruvate produced an alpha-tethered keto-enol tautomerized adduct.  The crystal structure 
containing the phenylaldehyde adduct combined with DFT calculations of potential FDC1 
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intermediates resulted in a proposed mechanism (Figure 3.2) involving a novel 1,3-dipolar 
cycloaddition.  The azomethine ylide of PrFMN is proposed to form a 1,3 dipolar cycloaddition 
with a ɑ, β -unsaturated bond of the phenylacrylic acid.  This is followed by a Grob-type 
fragmentation, after which glutamic acid 282 protonates the alpha tethered intermediate which 
results in a second 1,3 dipolar cycloaddition mechanism.  This results in a product-PrFMN 
adduct which then undergoes ring collapse to release the vinyl benzene derivatives and the 
PrFMN.  
Figure 3.2 (A) Proposed mechanism for the A. niger FDC1-catalyzed decarboxylation of phenylacrylic acid involving a 1,3-
dipolar cycloaddition to the PrFMN cofactor  (B) Proposed mechanism for the A. niger FDC1-catalyzed decarboxylation of phe-
nylacrylic acid involving a Michael addition-elimination reaction[51,56] 
A 
B 
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 The mechanism of FDC1 is of considerable interest because thermal pericyclic reactions 
are infrequent in enzymes, and 1,3-dipolar cycloadditions are unprecedented.  Based on the 
crystallographic evidence and the computational simulations the 1,3 dipolar cycloaddition 
mechanism is preferred over an alternative mechanism involving a Michael addition of PrFMN 
to the double bond of the phenyl acrylic acid followed by decarboxylation and elimination of the 
cofactor (Figure 3.2).  In this chapter, I investigate the mechanism using a combination solvent 
isotope effects, secondary isotope effects, NMR proton exchange experiments, and a linear free-
energy analysis to probe the enzymatic processes of the newly discovered PrFMN 
decarboxylase. 
 
3.2  Materials and Methods 
 
3.2.1 Materials 
 
trans-cinnamic acid, styrene, para-coumaric acid, 4-methoxycinnamic acid, 4-
fluorocinnamic acid, 4-formylcinnamic acid, 4-bromocinnamic acid, 4-chlorocinnamic acid and 
4-methylcinnamic acid were purchased from Acros Organic. Trans-cinnamic acid, 3-
nitrocinnamic acid, and 3-methoxycinnamic acid were obtained from Sigma Aldrich Co.  4-
cyanocinnamic acid was purchased from Matrix scientific. 4-aminocinnamic acid and 4-
nitrocinnamic acid were purchased from Tokyo Chemical Industries. 4-(2-carboxy-vinyl)-
benzoic acid methyl ester was purchased from Santa Cruz Biotechnology. All other chemicals 
were purchased from Sigma Aldrich Co. 
d7-trans-cinnamic acid and 3-d1-trans-cinnamic acid were purchased from Sigma-
Aldrich, 2-d1-trans-cinnamic acid was synthesized by reaction of benzaldehyde with d6-acetic 
anhydride using standard literature procedures.  
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Holo-FDC1 was recombinantly expressed in E. coli and purified as described previously. 
 
3.2.2. Determination of kcat/KM by U.V.-Visible Spectroscopy 
 Assays of FDC1 activity were routinely performed in 100 mM phosphate buffer (pH 7.4) 
at 25 ºC.  Stock solutions of the substrates were prepared in DMSO.  Assays contained substrates 
at various initial concentrations between 10 and 50 µM.  Reactions were initiated by the addition 
of FDC1 to a final level between 50 and 500 nM depending on the activity of the enzyme with a 
substrate.  The kinetics of the substrates was monitored spectrophotometrically, using an 8543 
Hewlett Packard spectrophotometer, by monitoring depletion of the substrates.   
3.2.3.  Determination of the Extinction Coefficient of Each Substrate 
 A 1mM stock solution of each substrate was made up in 100 mM pH 7.5 phosphate    
buffer.  A calibration curve was constructed using five concentrations between 5 µM and 100 
µM  using the 8543 Hewlett-Packard spectrophotometer.  The wavelengths used to watch the 
enzyme activity, and extinction coefficients of the various substrates are given in Table 3.1  
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Table 3.1 Assay wavelengths and extinction coefficients for phenylacrylic acid derivatives used in this study. 
 
3.2.4. Synthesis of β Deuterated trans-Cinnamic Acid 
 0.84g(0.0082 mol) Potassium acetate (Fisher) was weighed out into a three-necked 
round-bottomed flask. The flask was then heated in an oil bath to 170-190 
o
C while under dried 
nitrogen. Passing dry nitrogen and warming the round bottom flask served to remove any 
moisture from the base and the vessel.  
Substituent 
 
Assay wavelength 
(nm) 
 
ε substrate 
(M-1 cm-1 ) 
 
ε  product 
(M-1 cm-1 ) 
 
p-NH2- 
 
292 
 
17900 
 
1840 
 
p-HO- 
 
294 
 
16900 
 
7930 
 
pCH3O-  
 
290 
 
18900 
 
5410 
 
pCH3-  
 
280 
 
19000 
 
N/A 
 
p-H- 
 
276 
 
17900 
 
N/A 
 
p-F- 
 
276 
 
14300 
 
948 
 
m-CH3O-  
 
276 
 
14300 
 
N/A 
 
p-Cl- 
 
280 
 
21200 
 
1810 
 
p-Br- 
 
278 
 
22000 
 
2630 
 
p-CH3OOC-  
 
300 
 
19000 
 
N/A 
 
m-NO2- 
 
280 
 
14800 
 
7240 
 
p-CN- 
 
284 
 
26600 
 
7230 
 
p-CHO- 
 
304 
 
24800 
 
N/A 
 
p-NO2- 
 
314 
 
18000 
 
9760 
  
52 
 
2.5 mL (0.0094 mol) Benzaldehyde (Sigma-Aldrich) was dried over molecular sieves (Sigma) 
and introduced into the two-necked round-bottomed flask via a glass syringe. The flask also 
equipped with a drying tube (Dririte), and reflux condenser. A stir bar was introduced. 
5.0g (0.049 mol) Acetic anhydride d6 (Sigma-Aldrich) was introduced into the flask via a glass 
syringe. The drying tube was removed after five minutes, and dried nitrogen flowed through the 
apparatus. 
 The reaction proceeded for 14 hrs at between 165 - 200 
o
C.  After the reaction progressed 
for one hour TLC (alumina plate eluted with 60/40  EtOAc/Hexane) showed the presence of 
TCA (co-spotted with standard). After 14 hrs a solid reddish-brown solid oil was present in the 
flask.  To this extract the TCA from the reddish-brown oil approx. 50.0mL MeOD was added 
with 3 g of activated carbon.  This solution was heated to boiling briefly and gravity filtered 
while hot. The resulting clear solution was pD adjusted to pD 2 using concentrated DCl, which 
resulted in a white precipitate formed, which was then filtered.  The charcoal cake residue in the 
filter was washed with more MeOD.   After a few washes, the filtrate started becoming yellowish 
colored. The decolorization of the crude material indicated that the impurity was removed by the 
charcoal. Any colored filtrates were treated separately from the clear filtrates. These subsequent 
washes were pD adjusted and filtered as well. The crude d1-TCA (0.60 g) was recrystallized by 
adding approx. 10mL D2O to the crude in a 150mL beaker, and heating to near boiling. This was 
followed by dropwise addition of MeOD until everything was dissolved. The beaker was allowed 
to cool to room temperature. The white translucent plate-like crystals formed immediately and 
were filtered and 1:1 mixture of D2O and MeOD. 
1
HNMR confirmed the alpha-deuterated TCA 
(94-95% deuterated) as evidenced by a very diminished doublet at 6.5ppm (protonated alpha 
proton) relative to the beta proton at 7.8ppm. Yield was found to be 16%[89]. 
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3.2.5. Preparation of the Deuterated Buffers 
  100 mM solutions buffers at various pHs were used to study the FDC activity as 
followed:  pH 4.0-6.5, 100mM sodium citrate; pH 6.5-8, 100 mM sodium phosphate; pH 8.0-9.0, 
100mM Tris Chloride. The buffer salts were dissolved in 99.8% D2O and lyophilized, three 
times, to produce deuterated buffers. The pD of the buffers were either raised or lowered using 
DCl and NaOD.  Mixed D2O / H2O buffers were prepared at various mole fractions by 
combining deuterated and proteated buffers to the desired ratios, differences in molar volumes 
between H2O and D2O were accounted for using the values of 18.126 mL/mol and 18.058 
mL/mol respectively.  The mole fraction of D2O in each assay was re-calculated to account for 
the isotopic purity of D2O.  The enzyme was buffer exchanged in the D2O buffer and the mixed 
D2O / H2O buffers.  pL was correct using equation 2 where χ is the mole fraction of D2O[90]. 
Equation 3                                                                     𝑝𝐿 = 𝑝𝐻𝑜𝑏𝑠 + 0.311𝑥 + 0.0766𝑥
2 + 0.00009 
3.2.6. Deuterium Exchange Using 
1
H NMR 
 Carbon dioxide was removed from the deuterated citrate buffer by first bubbling argon 
through a sodium hydroxide solution, and then carbon dioxide was thoroughly removed from the 
deuterated citrate solution. Samples were prepared by buffer-exchanging the protein solution 
three times by repeatedly concentrating the protein in a 30kDa amicon filter and then diluting the 
protein solution in the deuterated citrate buffer pD 6.5.  Proton exchange was monitored using 
1
H 
NMR at 400 MHz with 1-s pulses at a 60º angle at 22
 o
C and following the disappearance of the 
styrene resonance at 5.2 ppm.  The reaction buffer was compromised with 100mM potassium 
citrate in D2O (pD = 6.5) 10 µM FDC, 10mM KHCO3, and 2.5 mM styrene[91]. 
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3.2.7 GC-MS Experimental Protocol for Constructing a Yield-Based Proton Inventory 
 To measure the intrinsic solvent deuterium isotope effect on styrene formation, the 
reactions were performed in buffers containing various mole fractions of D2O.  The protein was 
exchanged into the various buffers before the addition of the substrate to reduce the H2O 
contribution as much as possible from the enzyme stock solution.   To quantify the amount of H-
styrene and D-styrene the reactions were quenched by the addition of 500 µL of ethyl acetate and 
the styrene was extracted after 2 minutes.   The products of the reaction were then loaded on a 
Shimadzu QP-2010 GC-MS system equipped with a DB-5 column (30 m x 0.25 mm x 0.25 µm).  
The flow rate of the helium carrier gas is constant at 1 mL/min the inlet temperature was 
maintained at 200ºC.  The interface temperature was maintained at 250
 o
C.  Injections (8 µL) of 
the ethyl acetate extracted were made in splitless mode.  The oven temperature was held initially 
at 40
 o
C for 3.5 min, gradually increased to 90
 o
C at 14
 o
C /min, then gradually increased from 90
 
o
C to 315
 o
C at 20
 o
C /min, and finally maintained at 315
 o
C for 1 min.  GC-MS PostRun analysis 
software analyzed chromatographic data.  The styrene peak was resolved at the 7.6-minute mark 
of the run.  D-styrene intensity was corrected by removing the intrinsic 
13
C styrene 
contribution[90]. 
 
3.2.8. U.V.-Visible Protocol for the Determination of Secondary Kinetic Isotope Effects 
 Secondary KIEs were established at 280 nm, by monitoring the disappearance of TCA, 
each experiment was repeated 9 times to achieved to achieve the desired degree of precision. 
Secondary KIEs were established at a substrate concentration of 50 µM and enzyme 
concentrations of 50 nM so that the measurements represent the KIE on Vmax/KM.  Experiments 
were performed at a pD and pH of 6.5, where the activity of the enzyme is independent of pH. 
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3.2.9 Curve Fitting 
 Plots of kinetic data were generated, and curve fitting performed using the Origin 
Program (OriginLab).  The data for the description of FDC activity were fit to Eq. 4 which 
describes the relationship between the change in absorbance and the change in concentration of a 
substrate at a given time point.  The data for the description of mole fraction of styrene yields 
with respect to the mole fraction of the solvent were fit to equation 5.  Data describing 
log(kcat/KM) activity with respect to σ - was fit to equation 6. pKa values of FDC1 were 
determined using equation 7. 
Equation 4                                                                                                        𝑉 =   
(
∆𝐴𝑏𝑠
𝑑𝑡 )
(𝜀𝑤𝑎𝑣𝑒𝑙𝑒𝑛𝑔𝑡ℎ(𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒) ∗ [𝐸])
   
 Equation 5                                                                                                       χ𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑠  =  𝑆𝐼𝐸𝑜𝑏𝑠 (
1
𝜒𝑠𝑜𝑙𝑣𝑒𝑛𝑡
− 1) 
 Equation 6                                                                                                                                      𝜌 =  𝜎log (
(
𝑘𝑐𝑎𝑡
𝐾𝑀
)
𝑋
(
𝑘𝑐𝑎𝑡
𝐾𝑀
)
𝐻
 
Equation 7                                                                                   𝑘𝑐𝑎𝑡  =  
𝑉𝑚𝑎𝑥
(1 + 10𝑝𝐾𝑎1−𝑝𝐻 + 10𝑝𝐻−𝑝𝐾𝑎2)
 
 
3.3 Results 
3.3.1  Linear Free Energy Analysis 
 Linear free-energy relationships provide a powerful tool with which to interrogate 
reaction mechanisms.  Hammett analysis is rarely used in enzymology due to the narrow 
substrate range of most enzymes, although, for more promiscuous enzymes, linear free energy 
analysis proves to be highly informative[92, 93].  Interpretation of LFERs is often complicated 
by additional considerations such as differences in  hydrophobicity or Vander der Waal’s radius. 
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Thus single parameter linear free energy analysis is seldom possible to analyze the relationship 
between an enzyme and its substrates.  The broad substrate range of FDC1 makes it an excellent 
candidate to conduct a Hammett analysis of its decarboxylation mechanism[27].  The kinetics of 
decarboxylation were studied for a series of 14 para- and meta-substituted phenylacrylic acids 
and related to a series of parameters including; σ, σ -, σ +, and hydrophobicity.   
 The Hammett analysis suggests that among the substrates examined the most kinetically 
significant attribute was the negative electronic substituent parameter. σ – which is generally 
associated with phenols, anilines, and other groups with loosely held lone pair electrons 
conjugated with a substituent capable of accepting a lone pair of electrons via resonance.  The 
most widely accepted systems for defining σ –  is aniline, due to the ability of the lone pair of 
electrons to readily delocalize and reform the immine resonance structure.  In the mechanisms 
presented a σ –   would be appropriate with a lone pair of electrons is reacting from either the 
amine group, in the case of the 1,3 dipolar cycloaddition mechanism or having the electrons from 
the carboxylate group moving to fill the electron hole that would exist after the gamma-carbon 
PrFMN bond breaks pushing electrons back onto the PrFMN[92].   Interestingly and 
unexpectedly, for a decarboxylation reaction, ρ is negative (ρ = -0.39)(figure 3.3).  This points to 
a few things, first a chemical step in the reaction as the rate-determining step, rather than a 
substrate-binding or product release step, in which case the ρ would be expected to be close to 
zero.  Secondly, the negative rho value is consistent with a buildup of positive charge in the rate 
determining transition state, unlike most decarboxylation reactions where the decarboxylation 
would result in buildup of negative charge leading to a positive ρ value.  Therefore, it seems 
unlikely, regardless of the precise details of the mechanism, that the decarboxylation step is rate-
determining[94].  
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Table 3.2 kcat/KM values measured for FDC-catalyzed decarboxylation of various phenylacrylic acid derivatives 
 
Substituent 
 
σ – 
 
kcat /KM (M-1 s-1 ) 
 
log(kcat /KM ) 
 
p-NH2- 
 
-0.66 
 
12400 ±674 
     
   4.09 ± 0.023 
p-HO- -0.37 4550 ± 247 3.66 ± 0.023 
pCH3O-  -0.27 28100 ± 1800 4.45 ± 0.027 
pCH3-  -0.17 27000 ± 1600 4.43 ± 0.025 
p-H- 0 24500 ±1450 4.39 ± 0.023 
p-F- 0.02 27500 ±1760 4.44 ± 0.027 
m-CH3O-  0.12 27000 ± 2000 4.44 ± 0.031 
 
 
 
p-Cl- 0.23 19700 ± 1210 4.29 ± 0.026 
p-Br- 0.26 21400 ± 1320 4.33 ± 0.026 
p-CH3OOC-  0.66 11500 ± 322 4.06 ± 0.012 
m-NO2- 0.71 14300 ± 1020 4.16 ± 0.030 
p-CN- 0.88 12800 ± 884 4.11 ± 0.029 
p-CHO- 1.13 8690 ± 305 3.88 ± 0.015 
p-NO2- 1.25 8690 ± 162 3.94 ± 0.008 
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3.3.2 pH dependence and solvent isotope effects 
 Initial characterization by 
1
H NMR of the styrene produced in the FDC1 reaction 
established that the solvent proton is incorporated trans to the phenyl ring of styrene, as 
evidenced by the disappearance of the signal at 5.2 ppm when the reaction was performed in 
D2O (Figure 3.5).  Therefore, decarboxylation occurs with the retention of configuration at Cα, 
which is in accord with the geometry of the active site and the proposed role of Glu285 acting as 
the proton donor[51]. 
 Because pH may influence solvent isotope effects, I first investigated the activity of 
FDC1 as a function of pH and pD.  Under Vmax conditions, the enzyme exhibits a bell-shaped pH 
Figure 3.3 Hammett analysis of FDC1-catalyzed decarboxylation of 12 different para- and meta- substituted         
phenylacrylic acids 
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dependence, typical of many enzymes, with an activity maximum at pH 6.5.  the acidic limb is 
characterized by pKa = 5.3 ± 0.1, and the basic limb is characterized by a pKa = 8.0 ±  0.1.  the 
enzyme activity determined in deuterated buffers was found to be very similar, although the pKa 
of the acidic limb was shifted to a lower value (pKa = 5.0 ±  0.1) (Figure 3.5).  Using the pH & 
pD curve the solvent isotope effect on Vmax was found to be close to unity (
D
Vmax = 0.95 ± 
0.05; n = 5), indicating that proton transfer to the product is not a kinetically significant step in 
the determination of kcat[90, 95]. 
 
Figure 3.4 pL-rate profile for decarboxylation of trans-cinnamic acid by FDC in H2O (blue) and D2O (red) 
buffers kinetic data was fit to equation 7 
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 To investigate the protonation step in more detail, I conducted a proton inventory 
analysis, which enabled measurements on the solvent KIE on Vmax/KM).  Reaction mixtures were 
set up at pL 6.5 in buffers containing 0.1 mole fraction increments of deuterium (χD2O).  The 
styrene produced by the reaction was isolated, and the mole fraction of deuterated styrene 
(χstyrene) was determined by GC-MS.  While 
D
V/Ksolvent was determined to be 
D
V/Ksolvent = ~3.3±  
0.09, this was determined by fitting the proton inventory to equation 2[90, 96, 97]. 
 
A B 
Figure 3.5  (A) Proton inventory  for FDC.  The mole fraction of D2O in the solvent is plotted against the ratio of protonated to 
deuterated styrene.  the solid red line represents the best fit to deuterated styrene.  The solid red line represents the best fit to 
equation 2.  (B) A linearized plot of the data.  The data was fit to equation 4 
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From this analysis, a substantial solvent KIE on Vmax/Km is evident, with 
D
(V/K)solvent = 
3.33 ±  0.09.  I note that the equation above assumes that only a single proton is in motion in the 
transition state; the high fidelity of the fit suggests that this assumption is valid. The φobs , which 
is the inverse of the 
D
(V/K)solvent is 0.300 which too low for an equilibrium isotope effect with a 
single proton in motion, indicating that this isotope effect observed is likely a kinetic primary 
solvent isotope effect[96].  KIEs on Vmax are observed only if the isotopically sensitive step is 
rate-determining under saturating substrate conditions, whereas the KIE on Vmax/Km represents 
the KIE determined at low substrate concentrations and reflected all steps up to and including the 
first irreversible step. The data, therefore, indicates that the steps that control Vmax/Km and Vmax 
are different[96].  These results are an indication that protonation of the product is associated 
with a significant energetic barrier that occurs before the first irreversible rate-determining step 
of the reaction[96, 97].  As discussed below, these steps are likely associated with the resolution 
of the PrFMN-product adduct.  This energetic barrier is unlikely the rate determining step that 
limits kcat, as this would be inconsistent with the fact that the solvent KIE on Vmax is unity and 
that secondary KIEs are normal rather than exhibiting an inverse KIE.  
 
3.3.3 Secondary Kinetic Isotope Effects. 
  Secondary kinetic isotope effects report on changes in the hybridization of bonds 
adjacent to the site of the reaction and may be either normal or inverse.  They are particularly 
informative for an examination of changes in the geometry of carbon atoms:  the transition from 
tetrahedral to planar geometry is associated with a normal secondary KIE, whereas the transition 
from planar to tetrahedral geometry is associated with an inverse secondary KIE.  To investigate 
the mechanism of the FDC1 reaction, secondary deuterium KIEs were measured at both the β - 
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and γ -positions of phenylacrylic acid in both D2O and H2O buffers (the commercially available 
γ -deuterated phenyl acrylic acid was also deuterated on the phenyl ring; the remote isotope was 
assumed not to influence the KIE at the γ -position).  KIEs were determined at 25 ºC in 100 mM 
sodium citrate buffer (pL = 6.5) by a direct comparison of reaction rates at low substrate 
concentrations relative to KM so that the measurements represent KIEs on Vmax/KM(Table 
3.3)[97].  
 In H2O, no apparent 2º KIE was observed at the β -position, whereas at the γ -position a 
large, normal 2º KIE was measured (2º
D
V/K γ H2O = 1.10 ±  0.03; n = 9).  In contrast, in D2O 
the apparent 2º KIE at the β -position became significantly (2º DV/Kɑ  = 1.12 ±  0.03; n = 9). 
When the KIE were measured in deuterium oxide, the 2º KIE at the β-position was suppressed 
and was unity within error.  When deuterated phenylacrylic acid was the substrate, large 2º KIE 
were measured in both H2O and D2O.  The fact that these KIEs are normal indicates that they 
both arise from the rehybridization of the β and γ -carbons from tetrahedral to planar geometry 
during the reaction[74, 96, 97]. 
 The secondary KIEs measured for FDC1 provide further evidence that a chemical step, 
rather than a substrate bidding or product release step, is rate determining. Normal 2º KIEs are 
observed ɑ- and β-position of phenyl acrylate, although they are solvent dependent which 
complicates their interpretation.  Normal 2º isotope effects are indicative of a change of 
geometry at the carbon atoms from tetrahedral to planar, which supports the formation of the 
styrene bond in the final cyclo-elimination reactions.  The change in the apparent 2º KIEs 
observed when the reaction is performed in D2O is unusual but may be explained by the fact that, 
when the β -carbon undergoes rehybridization, it contains additional deuterium from the solvent.   
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 This will introduce a cryptic 2 º KIE at a carbon that could mask the 2º KIE at the β-carbon.  
Along those same lines, this additional deuterium atom would explain the further increase in 2º 
KIE when the β, γ -deuterated substrates are used.  This normal solvent selective 2 KIE further 
suggests that the 1,3 cyclo-elimination reaction occurs in a concerted but asynchronous reaction. 
 
 
 
 
 
 
Figure 3.6 Representative curves for the secondary isotope effect assay with the teal squares being deuterated β, γ Cinnamic acid 
with blue diamonds representing TCA 
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Table 3.3  Summary of secondary kinetic isotope effects measured for the FDC1-catalyzed decarboxylation of 
deuterated phenylacrylic acids in H2O and D2O 
 
Deuterium position 
 
2
o
 
D
V/K (H2O) 
 
2
o
 
D
V/K (D2O) 
 
 
C- β 
 
 
0.99 ± 0.02 
 
 
1.12 ± 0.030 
 
 
C- γ 
 
 
1.10 ± 0.016 
 
 
1.01 ± 0.027 
 
 
C- β  and C- γ 
 
 
1.15 ± 0.017 
 
 
1.32 ± 0.035 
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3.3.4. Deuterium Exchange into Styrene. 
The decarboxylation catalyzed by FDC1 can be driven in the reverse direction in the 
presence of styrene and a high concentration of bicarbonate.  I used the reversibility of the 
reaction to examine the requirements for proton transfer between Glu285 and the substrate.  
Reaction mixtures were set up in citrate-buffered D2O solutions containing 2 mM styrene that 
were either purged of dissolved CO2 or supplemented with 20 mM KHCO3.  We monitored the 
exchange of deuterium into styrene using 
1
H NMR by following the disappearance of the 
resonance at 5.20 ppm.  The stereospecificity with which deuterium is incorporated in styrene is 
consistent with the α-carbon of the substrate.  If the ɑ-carbon was free to rotate about the Cɑ-Cβ 
bond that would have resulted in scrambling in the isotope. The experiment resulted in a sole 
simplification of the signal at 5.75 ppm due to the cis-C1 hydrogen from a doublet of doublets to 
a doublet together with a slight upfield isotope induced chemical shift.   
 In carbonate deficient systems, little to no exchange of the deuterium was observed 
(Figure 3.6), whereas the addition of potassium bicarbonate resulted in deuterium exchange into 
styrene occurring at a rapid rate with an apparent rate constant app of ~1.5 min
-1
.  This result 
demonstrates that CO2 must be present in the active site for protonation/deprotonation of the 
styrene-PrFMN adduct to occur.  This implies that the dissociation of CO2 does not occur until 
after the product is protonated when the reaction proceeds in the decarboxylation direction. 
 The deuterium exchange into styrene occurred quite rapidly with an apparent rate 
constant app of 1.5 min
-1
.  This incorporation of deuterium exchange occurred much more 
rapidly than the rate of carboxylation, as previously, of which takes multiple hours to undergo 
one turnover. 
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Time = 30 minutes       No HCO3
-
  
Figure 3.7 FDC-catalyzes deuterium exchanged into styrene in the presence of HCO3
-. 1H NMR spectra were recorded 
at 500 MHz at between 0 and 30 minutes after addition of FDC1.  The bottom spectrum was recorded under the same 
conditions in the absence of HCO3
-.   
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3.4.  Conclusion 
 The novel isopentenyl modification of FMN converts a cofactor generally associated with 
redox reactions into one that supports decarboxylation.  The proposed mechanism involving a 
1,3-dipolar cyclo-addition of PrFMN with phenylacrylic acid seems plausible, as the prenylation 
of the flavin introduces functionality into the cofactor which is expected to have a ylide character 
similar to that of an azomethine ylide (Figure 3.8).  The kinetic experiments described in this 
chapter provide some insight into the reaction mechanism and the rate determining step of the 
reaction.  The results do not definitively rule out the previously considered mechanism which a 
Michael addition of PrFMN to phenylacrylic acid facilitates decarboxylation. 
  
In light of the experiments presented above, the proposed Michael addition mechanism is less 
likely. The normal 2º KIE indicates the rate-determining step would show that rehybridization of 
the β, γ bonds which would accompany decarboxylation would be rate limiting.  These results 
Figure 3.8 Proposed mechanism for the FDC-catalyzed decarboxylation of phenylacrylic acid involving a 1,3 
dipolar cycloaddition to the PrFMN cofactor 
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are inconsistent with the negative ρ found in the Hammett analysis which suggests that 
decarboxylation is rate limiting.  
   These results are mostly consistent with the proposed 1,3-dipolar cycloaddition 
mechanism. However there are some key differences between the previously proposed 
mechanism and the mechanism supported by these experiments[51].  First the carbon dioxide 
does not seem to leave the active site during the course of the reaction, secondly the resolution of 
the PrFMN-product adduct seems to occur in an asymmetric manner, which is contrary to the 
previously described mechanism. The Hammett analysis and the secondary isotope effect suggest 
that the rate-determining step in the 1,3 dipolar cycloaddition mechanism is the resolution of the 
product-PrFMN adduct through a cyclo-elimination reaction.  This step would result in a build-
up in positive charge in the rate-determining transition state as well as the rehybridization of ɑ, β 
carbon of styrene from tetrahedral to planer geometry.  However, no direct evidence exists for 
the formation of these intermediates.  The substrate reactivity patterns and the kinetic analysis 
presented here are possibly useful in guiding efforts to engineer FDC1 towards alternative 
substrates and greater catalytic efficiency. 
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Chapter 4   
 
Mass spectrometry, Mutants, and U.V.-Visible spectrometry Analysis of Mechanistically 
Relevant Intermediates Using a Substrate Analog and Styrene 
 
The work described in this chapter has been partly published as Ferguson, K.L., 
Eschweiler, J., Rutolo, B., Marsh, E. N. G. (2017) Evidence for the 1,3-Dipolar Cycloaddition 
Mechanism in the decarboxylation of Phenylacrylic Acids Catalyzed by Ferulic Acid 
Decarboxylase. Journal of the American Chemical Society, 139, 10972-10975.  K.L. Ferguson 
designed and performed experiments relating to the inhibition of FDC1 by FNVB, and analyzed 
the results.  K.L. Ferguson and J. Eschweiler designed and analyzed the results of the Native 
Mass Spectrometry experiments.  J. Eschweiler solely performed all mass spectrometry 
experiments and provided computational support for the data provided.  K.L. Ferguson, J. 
Eschweiler, B. Ruotolo, and E.N.G. Marsh wrote the manuscript. 
 
4.1 Introduction 
  The mechanism by which FDC1 catalyzes the decarboxylation of phenylacrylic 
acids remains unsettled.  Based on the crystal structure of FDC1 reacted with phenylpyruvate, as 
well as the data described in the previous chapters, it is proposed that the decarboxylation of 
phenylacrylic acids involves a novel 1,3 dipolar cycloaddition mechanism.  Decarboxylation 
then occurs by a Grob-type elimination of carbon dioxide in which the flavin acts as an electron 
sink (Figure 4.1).  Protonation of this intermediate by active site glutamate residue yields a 
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styrene-PrFMN adduct that then undergoes a cyclo-elimination to release the product and reform 
the PrFMN[48, 83-86]. 
  
  The basis for this 1,3-dipolar cycloaddition mechanism is the azomethiline ylide 
functionality that the PrFMN contains, as nitrogen ylides are well known to undergo 1,3 dipolar 
cycloaddition reactions; however, ylides are also intrinsically nucleophilic[98, 99].  The 
cycloaddition mechanism of ylides are well known and well characterized in synthetic 
chemistry[98, 99]. The reaction is dominated by the interaction of the highest occupied 
molecular orbital (HOMO) of the ylide and the lowest unoccupied molecular orbital of the 
dienophile. It is possible to react FDC with a substrate analog with a low energy LUMO that 
would undergo a pericyclic reaction and form a stable intermediate that would allow for 
characterization[100]. 
 Substrate analogs that function as mechanism based inhibitor of enzymes have proven to 
be a potent tool to uncover intermediates in enzyme reactions[101].  (Z)-2-Fluoro-2-nitro-
Figure 4.1 Proposed mechanism for the FDC-catalyzed decarboxylation of phenylacrylic acid involving a 1,3 dipolar 
cycloaddition to the PrFMN cofactor 
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vinylbenzene (FNVB) was a promising candidate, as the nitro group, a strong electron-
withdrawing group, and an excellent isostere for a carboxylate group, and fluorine is also 
electronegative group and a good isostere for hydrogen[101-104].   
 Another method to trap mechanistically relevant intermediates is to utilize low activity 
mutants of an enzyme that accumulate mechanistic intermediates.  Several low activity mutants 
of the FDC1 homolog in A. niger, already were analyzed about their activity.  R173A, E277Q, 
and E282Q were all previously found to be inactive.  These inactive mutants have analogous 
residues in FDC1 in S. cerevisiae at Glu285, Glu 279, and Arg175.  Previous work hypothesizes 
that the Glu282 is responsible for the protonation of the intermediate complex (Figure 4.1) that 
leads to the generation of styrene and the reformation of the PrFMN cofactor.  No explanation 
was offered for the other two mutants being inactive, other than to suggest that these mutants 
change the U.V.-visible spectrum of the enzyme and thus may affect either the local cofactor 
environment, the relative concentration of the cofactor, or how the cofactor matures[80].  
Mutating Glu285 to alanine would possibly arrest the reaction before the protonation step, 
thereby allow for isolation and characterization of the initial 1,3 dipolar cycloadduct by tandem 
mass spectrometry and monitoring its formation by spectroscopy[51, 86]. 
  FDC1 is well characterized as a reversible decarboxylase that readily complexes 
with styrene with a high concentration of bicarbonate. Previously described work in chapter 2 
suggests that the proton exchange in the reverse reaction occurs with a rate of 1.4 min
-1
.  Thus if 
PrFMN readily forms the product-PrFMN adduct with a high concentration of bicarbonate 
making it possible to isolate and characterize these adducts by tandem mass spectrometry.  FDC1 
reacted with styrene and its d7-styrene analog and employing tandem mass spectrometry it might 
be possible to isolate a PrFMN-product intermediate.   
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    In this chapter, I describe a series experiments monitoring the interaction of the PrFMN 
and the proposed FNVB substrate analog.  Also, I collaborated with the Ruotolo lab here at the 
University of Michigan to probe FDC1 by native MS and to look for covalently modified 
PrFMN adducts including; Styrene-PrFMN, d7-Styrene-PrFMN, FNVB-PrFMN.  Finally, I 
performed mutagenesis on the Glu285 and Arg175 to slow the protonation step of the forward 
reaction and explore why these mutations limit the reactivity of the enzyme. 
  
4.2. Materials and Methods 
4.2.1. Materials 
Trans-cinnamic acid was purchased from Across Organic, and 2-fluoro-2-nitro-
vinylbenzene was purchased from Spirochem, Zurich.  All other reagents were purchased from 
Sigma Aldrich Co and were of the highest grade commercially available.  WT FDC1 from S. 
cerevisiae was purified as previously described in chapter 2 section 2.2.2 Invitrogen provided 
XL10-gold cells.  His-Trap HP (5 mL) Ni-affinity column was obtained from GE Healthcare.  
The QuikChange lighting kit and all materials associated materials were obtained from Agilent. 
 
4.2.2.  Site-directed Mutagenesis 
 E285A, E285Q, R175A, and R175K primers were designed using the 
QuikChange Primer Design tool, courtesy of Agilent and ordered from IDT technologies.  PCR 
reactions for the mutants were then performed according to the QuikChange Lightning Site-
Directed Mutagenesis Kit.  The reaction mixtures contain 5 µL 10x reaction buffer, 100 ng of the 
dsDNA template, 1 µL of dNTP mix, 1.5 µL of quick solution reagent, 125 ng of the forward 
and reverse primer, and finally enough nuclease-free water to increase the reaction volume to 50 
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µL.  The initiation of the PCR reaction followed the addition of µL of the QuikChange Lighting 
Enzyme. 
 A three-step PCR was run with an initial denaturing step at 95 ºC for two minutes, 
followed by 18 cycles of 95 ºC for 20 seconds, 60 ºC for 10 seconds, and then an elongation step 
of 68 ºC for 5 minutes.  The final elongation step consisted of holding the PCR reaction at 68 ºC 
for 5 minutes.  The parent plasmid template in the PCR mixture was then digested with 1 µL of 
DpnI, 1x NEB cutsmart buffer, and enough DNAse free water to bring the total reaction volume 
to 50 µL at 37 ºC for 2 hrs.  The mutant plasmid chemical competent XL-10 gold cells.  
The XL-10 gold cells were pre-chilled into 1.5-mL polypropylene round-bottom tube on 
ice.  100 µL of cells was placed into the pre-chilled tubes, and 4 µL of beta-mercaptoethanol mix 
provided by the XL-10 gold kit were aliquoted into the cells.  The cells were incubated on ice for 
10 minutes; the cells were swirled gently every 2 minutes.  2 µL of the DNA mixture was added 
to the chilled cells.  The DNA and cells were incubated then incubated on ice for 30 minutes.  
The cells were then heat-pulsed in the tubes in a 42 ºC water bath for 30 seconds.  The cells were 
then allowed to rest on ice for 2 minutes.  450 µL of SOC media was then added to the cells, and 
the cells could rest in an incubator at 37 ºC for 1 hr with gentle rocking.  The cells were then 
plated on kanamycin resistant agar.  Colonies were picked for overnight growth, and their DNA 
was purified and verified by sequencing.  Alignments to identify successful mutant were 
performed with Codon Aligner.  Mutant plasmids were then transformed into BL21(DE3) star 
cell lines for protein expression. 
 The BL21 (DE3) star OneShot cells were thawed gently on ice per 
transformation.  250 ng of DNA was added to 50 µL of cells and allowed to incubate on ice for 
30 minutes gently agitating the solution every 2 minutes.  The cells were then heat shocked for 
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30 seconds in a 42 ºC water bath for 30 seconds.  450 µL of SOC media was then added to the 
cells, and the cells could rest in an incubator at 37 ºC for 1 hr with gentle rocking.  The mutant 
cells were then plated on kanamycin resistant agar plates. 
 
4.2.3. U.V.-Visible Assay between FDC1 & FDC1 Mutants and FNVB 
 The reaction of FDC1 with 2-fluoro-2-nitrovinylbezene (FNVB) was performed 
in 100 mM citrate buffer (pH 6.25) containing 10% glycerol at 25 ºC.  A stock solution of FNVB 
(Spirochem, Zurich) was prepared in DMSO and diluted into the reaction buffer at various initial 
concentrations between 5 and 25 µM.  Reactions were initiated by addition of FDC1 to a final 
concentration 5 µM.  The reaction was followed spectrophotometrically by monitoring the 
decrease in absorbance at 326 nm assuming an extinction coefficient of 13,700 M
-1
cm
-1
.  
Typically, measurements were made over a period of 10 minutes with time points being taken 
every 10 seconds. Assays were done in triplicate to establish statistical significance. 
 
4.2.4.  U.V.-Visible Time Course Assay of the Reaction between FNVB and WT FDC1 
Assays were performed on a Hewlett Packard 8542 spectrophotometer.  The reaction 
of FDC1 with 2-fluoro-2-nitrovinylbezene (FNVB) was performed in 100 mM citrate buffer (pH 
6.25) containing 10 % glycerol at 25 ºC.   A stock solution of FNVB (Spirochem, Zurich) was 
prepared in DMSO and diluted into the reaction buffer at various initial concentrations between 5 
and 25 µM.  Reactions were initiated by addition of FDC1 to a final concentration 5 µM.  The 
reaction was followed spectrophotometerometrically by monitoring the decrease in absorbance at 
326 nm assuming an extinction coefficient of 13,700 M
-1
cm
-1
.  Typically, measurements were 
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made over a period of 2 minutes with points taken every 4 seconds.  Assays were done in 
triplicate to establish statistical significance 
 
4.2.5. Mass Spectrometry of FDC1 
 100 µL samples containing FDC, 50 µM were reacted with FNVB, 50 µM, as 
described above for 10 min.  Samples were buffer exchanged into 500 mM ammonium acetate 
buffer, pH 6.9 using two Micro Bio-Spin Columns (Bio-Rad, Hercules, CA).  The final 
concentration of the buffer exchanged protein was 5-10 µM. Samples were analyzed under 
native MS conditions using a Synapt G2 ion mobility mass spectrometry platform (Waters Inc, 
Milford MA).  The FDC1-FNVB native protein complex the capillary voltage was set to 1.5kV. 
 
4.2.6. MS
2
 Analysis of FDC1 
Apo-FDC, holo-FDC, and FNVB incubated FDC were ionized using nanoelectrospray 
ionization.  The initial instruments settings were set to minimize ion activation, thereby 
maintaining non-covalent interactions such that no significant signals were observed for free 
FMN-related peaks.  The capillary voltage was set to 1.5 kV, and the sampling and extraction 
cones were set to 30 V and 0 V, respectively with the trap collision energy at 20 V.   
For collision-induced dissociation experiments, the trap collision energy was raised to 
100 V to dissociate the noncovalently-bound species including; FMN, PrFMN, and the FNVB-
PrFMN adduct, giving rise to a series derived peaks at low m/z. Spectra were processed in 
Masslynx (Waters Inc, Milford MA). 
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4.2.7. Mass Spectrometry Analysis of R175A, R175K, E285A, E285Q Mutants 
100 µL samples containing FDC1, 50 µM were reacted with FNVB, 50 µM, as described 
above for 10 min.  Samples were buffer exchanged into 200 mM ammonium acetate buffer, pH 6 
using two Micro Bio-Spin Columns (Bio-Rad, Hercules, CA) except the R175K mutant which 
was exchanged into a 200 mM ammonium acetate buffer, pH 8.  The final concentration of the 
buffer exchanged protein was 5-10 µM. Samples were analyzed under native MS conditions 
using a Synapt G2 ion mobility mass spectrometry platform (Waters Inc, Milford MA).  The 
FDC1-FNVB native protein complex the capillary voltage was set to 1.5 kV. 
 
4.2.8.  MS
2 
Analysis of R175A, R175K, E285A, E285Q Mutants 
 R175A, R175K, E285A, E285Q FDC1 were ionized using nanoelectrospray 
ionization.  The initial instruments settings were set to minimize ion activation, thereby 
maintaining non-covalent interactions such that no significant signals were observed for free 
FMN-related peaks.  The capillary voltage was set to 1.5 kV, and the sampling and extraction 
cones were set to 30 V and 0 V, respectively with the trap collision energy at 20 V.   
For collision-induced dissociation experiments, the trap collision energy was raised to 
100 V to dissociate the noncovalently-bound species including; FMN, PrFMN, and the many 
other adducts, giving rise to a series derived peaks at low m/z. Spectra were processed in 
Masslynx (Waters Inc, Milford MA). 
 
4.2.9. MS
2
Analysis of Styrene-PrFMN Adduct 
 100 µL samples are containing FDC, 100 µM were reacted with styrene, and 
200m M NH4OAc pH 6.5, 100 µM, and 10 mM NH4HCO3 as described above for 10 min.  
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Samples were buffer exchanged into 200mM ammonium acetate buffer, pH 6.9 using two Micro 
Bio-Spin Columns (Bio-Rad, Hercules, CA).  The final concentration of the buffer exchanged 
protein was 25 µM.  
The FDC1 with the Styrene-PrFMN adduct was ionized using nanoelectrospray 
ionization.  The initial instruments settings were set to minimize ion activation, thereby 
maintaining non-covalent interactions such that no significant signals were observed for free 
FMN-related peaks.  The capillary voltage was set to 1.5kV, and the sampling and extraction 
cones were set to 30V and 0V, respectively with the trap collision energy at 20 V.  For CID 
experiments, the trap collision energy was raised to 100 V to dissociate the noncovalently-bound 
FNVB-PrFMN adduct, giving rise to a series of Styrene-PrFMN derived peaks at low m/z. 
Spectra were processed in Masslynx (Waters Inc, Milford MA)[54]. 
 
4.3. Results 
4.3.1. Mass Spectra Analysis of holo-FDC1, apo-FDC1, and FNVB Bound FDC1 
Native mass spectra are shown in Figure 4.2, of apo-FDC1, holo-FDC1, and FNVB 
incubated FDC1 electron sprayed under physiological-pH conditions (500 mM ammonium 
acetate, pH 6.9).  FDC1 is a dimer species.  FDC1 in the apo form presents a variety of charge 
states ranging from [2M+19H]
19+ 
to [2M+24H]
24+
, with the [2M+21H]
21+
 being the most intense 
mass charge peak.  FDC1 in the holo form and with FNVB bound exhibits narrower range of 
charges from [2M+19H]
19+
 to [2M+22H]
22+
.  However, for holo-FDC the most intense peak is 
+20 species, bound enzymes however exhibit the most intense charge peak at +21.  This data is 
consistent with all other previous MS investigations of FDC1[55]. 
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A 
B 
C 
m/z 
Figure 4.2 (A) Native mass spectrum of the apo-FDC1.  (B) Native mass spectrum of the holo-FDC1.  (C) Native 
mass spectrum of holo-FDC1 incubated with FNVB 
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The holo-FDC1 spectrum in Figure 4.2 arises predominantly form protein dimers with 
two non-covalently bound cofactors, with approximately a third of the total ion intensity 
attributed to the protein with one non-covalently bound cofactor and just a small amount of  
protein, is observed without any cofactor.  In contrast upon the addition of the FNVB, the 
apo-protein is essentially absent, and the doubly occupied accounts almost all of protein species 
observed.    
 The mass of the inhibitor bound FDC1 is larger than the mass of the doubly 
bound holo-FDC1 by 290 daltons, which is 44 daltons lower than that of the mass that would 
result from 2 inhibitor molecules being directly bound to holo-FDC1. The mass difference 
between the singly inhibitor bound and doubly inhibitor bound holo-FDC1 is 660 daltons, which 
is 32 daltons less than the predicted mass of the PrFMN-Inhibitor complex of 692 daltons. 
  
4.3.2 MS
2
 Analysis of holo-FDC1, apo-FDC1, and FNVB Bound holo-FDC1 
 
 Native tandem mass spectrometry of apo-FDC1, holo-FDC1, and inhibitor-bound holo-
FDC1 allowed for the dissociation of non-covalently bound species from the enzyme.  Apo-
FDC1 exhibited a dominant peak at m/z 457.143 [M+H]
+
, representing FMN which has been 
shown to bind to FDC1 lacking the PrFMN cofactor species.  The holo-FDC1 exhibits a 
dominant peak at 525.17 [M+H]
+
 as well as a peak at 563.17 due to the potassium adduct 
[M+K]
+
.  The potassium adduct may form the potassium ion found to be in the active site of 
FDC1, as the buffers all lack potassium, indicating that the PrFMN is indeed dissociating from 
the active site of FDC1.  The inhibitor FDC1 complex exhibits several unique peaks in addition 
to the familiar m/z peaks of 525.175 and 563.17.  The unique m/z peak of 730.167 is the ion with 
the highest intensity and corresponds the mass of the inhibitor-PrFMN cycloadduct complexed to 
a potassium ion.  The other unique mass ion peaks at 683.189 and 645.227 are either likely 
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breakdown products associated with the inhibitor-PrFMN cycloadduct complex or small mass 
peaks intrinsic to the protein.  The 645.227 and 683.189 peaks could match the previously 
described phenylaldehyde-PrFMN protonium adduct and the corresponding potassium 
adduct[51]. 
A 
B 
C 
Figure 4.3 (A) Tandem mass spectrum of apo-FDC1 (B) tandem mass spectrum of holo-FDC1 (C) tandem mass spectrum of holo-
FDC1 incubated with FNVB 
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4.3.3 MS
2
Analysis of holo-FDC1 Reacted with Bicarbonate and H8 & D8 Styrene 
 The reversible nature of FDC1 along with the gentle nature of tandem mass spectrometry 
allowed for the identification of product-PrFMN adducts formed during the reverse reaction.  
The styrene-incubated FDC1 exhibited unique peaks which represent the PrFMN-styrene 
complex with a mass of 629.258 [M+H]
+
 and 667.218 [M+K]
+
.  The d8 styrene exhibited unique 
peaks which represent the d8-PrFMN-Styrene complex with a mass of  636.271 [M+H]
+
 and 
674.247 [M+K]
+
 which represents a 7-dalton shift.  The terminal trans-hydrogen of styrene was 
previously shown to readily exchange with the surrounding solvent, which explains why there is 
only a 7 Da shift instead of the expected 8 Da shift. 
 
 
 
 
  
81 
 
 
Figure 4.4 MS2 of FDC1 incubated with d8-styrene, styrene, FDC1 incubated FNVB, holo-FDC1 
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4.3.4 U.V.-Visible Analysis of holo-FDC1 Reacted with FNVB 
 When holo-FDC1 reacts with FNVB the U. V. –visible spectrum exhibits a decrease in 
absorbance at 326 nm while generating a new absorbance band centered on 425 nm.  The 
decrease in the absorption occurring at 326 nm is characteristic of disruption of the extended pi-
system that is characteristic of FNVB.  Additionally, a new weaker absorption band centered at 
440 nm appears[54, 80, 105-107]. 
 Flavins possess rich and informative electronic spectra that are indicative of both redox 
and protonation states and are sensitive to changes in the substitution pattern of the isoalloxazine 
ring system[105].  U.V.-Visible spectra have been characterized for both C4ɑ, N5-dialkyl flavins 
and N5-alkyl flavinium cations, which correspond to the reaction of FNVB with PrFMN by 
either cyclo-addition or Michael addition mechanisms.  C4α, N5-dialkyl flavins have a 
characteristic absorbance at ~400 nm that is sensitive to the electronic properties of other 
substituents on the complex.  In contrast, the N5-alkyl flavinium cation is characterized by strong 
absorption bands at 350 and 550 nm.  The spectrum of the PrFMN-FNVB product, with its broad 
absorbance band at 425 nm, is indicative of the formation of a cycloadduct, rather than a Michael 
addition adduct. 
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Figure 4.5 FDC1 incubated with FNVB over the course of 2 minutes  
Figure 4.6 Time dependent difference spectra between FDC1 incubated with FNVB and FDC1 at spectra time equals 0 
and time equals 2 minutes 
∆
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4.3.5. Inhibition Rate of Holo-FDC1 Reacted with FNVB 
 FNVB was reacted with 5 µM of FDC1 and the decrease at 326 nm was fit to a first-order 
kinetic model, as this reaction results in a dead end enzyme-inhibitor complex.  The reaction rate 
was 0.64 ± 0.04 min
-1
.  FNVB was shown to be a potent inhibitor, as the reaction rate was 
independent of FNVB concentration within the ability to measure the reaction.  These 
observations indicate that the observed rate constant represents the true rate constant of a 
chemical step representing the reaction between FNVB and PrFMN rather than FNVB binding to 
the enzyme. 
 
Figure 4.7 Time dependent spectrum of FDC1 incubated with FNVB at 325nm 
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4.3.6 Mutagenesis 
 Based on the analysis of the crystal structure and previous mutagenesis work [51, 57] two 
amino acids in the active site were chosen to be mutated:  E285 and R175.  E285 has previously 
been proposed as general acid in the FDC1 catalytic cycle, and thus mutating out E285 should 
slow the reaction, hopefully revealing mechanistic intermediates before the protonation step 
through either U.V.-Visible spectroscopy or tandem mass spectrometry.  The other candidate 
was R175, as previously established alanine scanning mutagenesis suggested that this residue 
was responsible for both cofactor binding and maturation[57]. These mutants exhibited 
considerably less activity, together with altered U.V.-visible spectra, and new tandem mass 
spectrum peaks compared to the wildtype enzyme. 
 
4.3.7. Spectroscopic Characteristics of the R175A, R175K, E285A, E285Q Mutants 
 These amino acids have previously been described, but there was only limited 
information on how these mutations affect the spectra of the PrFMN[51]. The R175A and 
R175K mutants both exhibited weak spectral features[51].  One explanation for this is that 
Arg175 is responsible for binding the cofactor to FDC1, thus mutating Arg175 to alanine or a 
more flexible lysine prevents the cofactor to binding.  A second hypothesis postulated by Bailey 
et al. 2017 is that arginine 175 plays a role in the oxidative maturation of the reduced PrFMN to 
the active immine oxidized PrFMN[57]. 
 
4.3.8.  Activity of the R175A, R175K, E285A, E285Q Mutants with TCA and FNVB 
 Active site mutants R175A, R175K, E285A, E285Q, exhibited a considerable decrease in 
activity. E285A and E285Q exhibited no discernable activity.  This reduction in activity is 
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consistent with previous results that postulate that the replacement of the E285 with an alanine or 
a glutamine mutation removes the general acid responsible for the protonation of the product 
[57]. The E285A did not bind FNVB, which readily outcompetes the native substrate to bind and 
inactivate FDC.  One possibility is that on the E285 residue plays a role in stabilizing the 
interaction between the PrFMN and the inhibitor.  E285Q did not exhibit any activity with the 
native substrate.  The E285Q mutant interaction with the inhibitor was nonexistent at pH 6.5.  
This could be due to a change in the charge state of the active site compared to the wild type.  To 
probe whether or not the change in the charge state of the active site affects the binding of the 
inhibitor the experiment was repeated at pH 10.  At pH 10 the inhibitor did bind to the PrFMN as 
noted by the decrease in the absorbance maxima of the inhibitor at 350 nm signifying that active 
site cannot be positively charged, otherwise the substrate will not bind. 
 The R175A and R175K mutants exhibited considerably reduced activity, as determined 
by GC-MS and UV-Vis with a kca value of 0.84 µM
-1
 min
-1
, which resulted in a 99.9% reduction 
in activity.  This reduction in activity has been attributed to the R175A and R175K variants 
being unable to oxidize the PrFMN to the iminium form of the cofactor, regardless of the 
evidence that the oxidation or PrFMN can occur independently of FDC1 [57, 108].  In light of 
this and additional tandem MS experiments noted below, an alternative explanation is that the 
R175 amino acid is directly involved in the binding of PrFMN, thus mutating R175 results in the 
Kd of PrFMN becoming too large to get high incorporation of PrFMN into FDC1.     
 
4.3.9. MS
2
analysis of the R175A, R175K, E285A, E285Q mutants 
  10 µM solutions of each mutant were subjected to native mass spectrometry
 and tandem mass spectrometry as described earlier.  The mutants’ protein spectra all 
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exhibited similar characteristics to the wildtype FDC spectra such as presenting as a dimeric 
protein with the most abundant charge state being +20.  However, there was considerable 
variation in the mass spectra of the cofactor of the mass spectrum of the mutant enzyme versus 
the wildtype tandem mass spectrum. 
 Both the R175A and R175K cofactors exhibit m/z values of 525.15, 547.14, and 563.15 
which corresponds to the [PrFMN+H], [PrFMN+Na], and [PrFMN+K] adducts which are all 
present in wild type FDC.  However, new peaks of higher intensity were observed with m/z = 
645.24, 667.206, and 683.17 which seems to mirror the proton, sodium, and potassium adducts 
that readily couple with PrFMN(Figure 4.8).  Analysis of the amount of PrFMN bound to the 
R175A mutant indicates that mutation of R175 to alanine dramatically lowers the amount of 
PrFMN bound to the protein (Figure 4.9). 
 The cofactor spectra of the E285A and E285Q mutants were similar to those of the 
arginine mutants.  The E285A mutant exhibited m/z peaks 645.24, 667.206, and 683.17 which 
represent a X+H, X+Na, and X+K adduct.  The E285Q tandem mass spec experiment was 
perfomred in pH 8 buffer; unknown peaks by 1 Da indicating that these species bound to the 
protein are pH sensitive, and that consistent choice of buffer conditions is needed to make 
reliable experimental observations. 
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D C B A 
Figure 4.8 (A) MS2 of the R175K mutant (B) MS2 of the E285Q mutant (C) MS2 of the R175A mutant (D) MS2 of the E285A mutant 
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4.4 Conclusion  
Before this study, direct spectrophotometric and mass spectrometry evidence for the 
existence of these proposed 1,3-dipolarcycloadducts was based on tendancy of azomethiline 
yilides to react by a 1,3-dipolar cycloaddition mechanism, as well as plant enzymes’ tendancy to 
undergo 1,3-dipolar cycloaddition reactions.  These results provide the first direct experimental 
evidence that this novel and structurally complex flavin-derived cofactor is reactive towards 1,3-
dipolar cycloaddition chemistry.  There is a distinct red-shift that results from complexing the 
inhibitor FNVB with PrFMN results in a new local maximum at 450 nm.  This type of 
spectrophotometric shift is characteristic of from a neutral, dialkylated flavin molecule, which 
has been shown with synthesized flavin derivatives.  These results are consistent with the mass 
spectrometry evidence where FDC1 incubated with FNVB forms a potassium adduct with a 1,3 
dipolar cycloadduct between the FNVB and the PrFMN.  Also, when styrene and bicarbonate 
were incubated together with FDC1 the styrene-PrFMN adduct could be detected by mass 
spectrometry. 
 The mutagenesis experiments presented above may provide some insight into the role of 
two residues critical to the activity of FDC1.  The R175 residue and the analogous R172 residue 
of FDC from A. niger were previously described by Bailey et al. 2017 as being critical to the 
oxidative maturation of the PrFMN cofactor, regardless of the previously reported work by 
Arunrattanamook 2017 that the cofactor of S. cerevisiae can oxidatively mature independent of 
the FDC1[108].  Comparing the mass spectrometry data for the wild-type FDC and the R175 
mutant instead suggest that the R175 mutant doesn’t bind PrFMN as tightly as the wild-type 
enzyme.  All the mutants, but especially the E285 mutants, showed several unknown higher 
molecular weight adducts that are bound to the enzyme.  These unknown species could be the 
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reason the enzyme spectra of these mutants are different from the wild-type enzyme. It is 
possible that these unknown spectra are either phenyl aldehyde PrFMN adduct 
The results presented here provide direct evidence to supports the Grob-Type 
decarboxylation mechanism in FDC1 that is facilitated by the formation of a pentacyclic 
prFRMN substrate adduct through cycloaddition, and the formation of a pentacyclic PrFMN 
substrate adduct through cyclo-addition.  Furthermore, the mass spectra data suggests that there 
could be some higher molecular weight species bound to FDC1 instead of the PrFMN.  Future 
experiments should focus on trying to fragment these higher molecular weight adducts to try to 
gain some structural insight into what these higher molecular weight adducts are.  Furthermore, 
introducing double mutants into the active site and observing the change in the distribution of 
these protein bound small molecules could elucidate whether these small molecules are PrFMN 
adducts such as the phenylaldehyde-PrFMN adduct or some form of proto-cofactor.  
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Chapter 5 Conclusions and Future Directions 
 
5.1. Overview 
 
 Investigations into ferulic acid decarboxylase from S. cerevisiae were motivated by the 
potential fo this enzyme to provide a sustainable route to produce  heavily utilized and valuable 
compounds including; styrene, vinyl guiacol, 1,3 pentadiene.  UbiD from P. aeruginosa and 
FDC1 from A. niger were identified as potential targets for antibiotic development.  UbiD plays 
a vital role in the synthesis of ubiquinone, which is essential for aerobic growth, and ubiquinone 
derivatives which serve as a vital signaling molecules in bacteria.  FDC1 from A. niger was 
identified as an antifungal target for its broad representation among fungi and its role as breaking 
down established antifungal compounds such as cinnamic acid and ferulic acid[77].  The 
FDC1/PAD1 decarboxylase system from S. cerevisiae was originally identified as a potential 
candidate for the sustainable production of plastic monomers and biofuels based on its ability to 
readily decarboxylate cinnamic acid as well as sorbic acid[54].  For either of these goals to be 
achieved, additional biochemical characterization of the system was needed, which has been the 
subject of this dissertation[52-54].  
 
5.1.1. The Relationship between FDC1 & PAD1 
  Both FDC1 and PAD1 or UbiX are necessary for phenylacrylic acid decarboxylation 
activity.  tPAD1 and FDC1 were independently expressed and purified FDC1 exhibited an initial 
activity of  0.54 µmol/(min*mg enzyme), however when FDC1 was dialyzed FDC1 lost its 
associated activity.  However, upon the addition of E. coli BL21 cell lysate to FDC1, the activity 
was restored, thus suggesting that FDC1 required a small molecular partner present in the cell 
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lysate.  UbiX, a PAD1 analog endogenous to E. coli was suspected to PAD1’s function in 
activating FDC.  This relationship was confirmed when a ∆ubiX E. coli Bl21 lysate failed to 
reactivate FDC, implying that UbiX was isofunctional with PAD1 as both were able to 
reconstitute FDC1.  To answer the question whether PAD1/UbiX directly interacted with FDC1 
and 6.7 mM of cinnamic acid, and tPAD1 with ∆ubix BL21DE cell lysate were placed opposite a 
3kDa membrane to see whether PAD1 produced a small molecule from the BL21 cell lysate 
which would then be uptaken by apo-FDC1 to facilitate the decarboxylation of cinnamic acid.  
Apo-FDC was reactivated under these conditions, showing that FDC1 is directly responsible for 
the decarboxylation activity, whereas PAD1/UbiX is responsible for the production of the 
recently identified, oxygen stable PrFMN cofactor.   
 
5.1.2. Mechanistic Study of the New PrFMN Decarboxylation Mechanism 
 Following the establishment of the relationship between FDC1 and tPAD1, crystal 
structures of both UbiX from P. aeruginosa and FDC1 from S. cerevisiae were reported.  The 
discovery of the PrFMN, with its novel isopentenyl modification, raised questions as to how it 
functioned in the decarboxylation mechanism.  With the crystal structures, two mechanisms were 
proposed a 1,3 dipolar -cycloaddition mechanism, a mechanism never seen before in 
biochemistry, and a more conventional Michael addition mechanism.  Potential mechanisms 
were investigated using isotope effects, NMR analysis, and a Hammett analysis.  The Hammett 
analysis with σ- correlation with which provided strong evidence that the rate determining step is 
chemical in nature.  The negative rho value (ρ = -0.39) for the Hammett plot indicated that the 
rate determining step involved a build-up of positive charge in the transition state, an observation 
that suggested that decarboxylation is not the rate determining step, because decarboxylation 
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reactions typically result in a build-up of negative charge.  The secondary deuterium isotope at 
the ɑ or β carbons is normal, which suggests that the rate determining step involves the 
rehybridization of these bonds from an sp
3
 to an sp
2
. Also, the secondary isotope effects are 
solvent dependent suggesting that the rehybrization of these carbon centers occur 
asynchronously. These effects suggest the Michael addition mechanism as unlikely, as these 
results suggest that the rate determining steps is chemical in nature, and Hammett analysis 
suggests that decarboxylation is not the rate determining therefore either formation the michael 
adduct would be rate determining, or the break of the PrFMN-Michael complex would determine 
the rate of the reaction. The normal isotope effects suggest that the formation of the Michael 
complex, would not be the rds. as that would result in inverse secondary KIE.  These results 
would lead to the breaking of the PrFMN-Michaelis complex as rate determining and the solvent  
isotope effects suggest that the breaking of this bond would have to precede decarboxylation due 
to the large KIE on (V/K) and computational studies suggest that this is energetically 
unfavorable, and thus the Michael addition-elimination mechanism seems unlikely[84].  The 
evidence therefore suggests that the presented 1,3 dipolar cycl-addition  mechanism is a likely 
candidate for the enzymatic mechanism.  However, the NMR deuterium exchange experiment 
suggests that carbon dioxide does not immediately diffuse from the enzyme because for 
protonation to occur carbon dioxide needs to be bound to the enzyme.  
 
5.1.3. Trapping Mechanistic Intermediates 
 Following the initial mechanistic investigation, substrate analogs and mutants were 
employed in an attempt to trap the putative cyclo-adduct.  Alpha-fluoronitrovinylbenzene, was 
considered to be a good isostere for cinnamic acid with the nitro and fluoro groups activating the 
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double bond for cycloaddition[104].  FNVB was found to be a potent inhibitor of FDC1 
1exhibiting a Ki value in the nanomolar range.  FNVB reacted with FDC1 to produce an enzyme 
bound species with a new U.V.-visible spectrum, which suggested that the substrate analog 
formed a complex with the PrFMN.  FDC1 was briefly incubated with FNVB for and then 
subjected to tandem mass spectrometry to identify small molecules bound directly to the enzyme.  
Incubation with FNVB resulted in a new peak of mass 731.2 daltons which was found to 
represent PrFMN - FNVB cycloadduct complexed with a potassium ion.  Slow mutants of FDC1, 
were exploited to isolate and characterize either the product-PrFMN adduct or the substrate-
PrFMN complex.  Styrene-PrFMN and d7-styrene-PrFMN complexes were readily isolated by 
mass spectrometry.  The mutants revealed a change in the distribution of bound species to FDC.  
The 667 mass peak increased in intensity in the E285 mutants, while the 525 mass peak 
decreased significantly.  The R175 mutants appeared to bind PrFMN significantly less  tightly 
525 simply, but this mutation did not alter the relative intensity of the 667 peak. 
 
5.2 Future Directions 
5.2.1. Transient Kinetics and Future Isotope Effect Measurements 
 
 Further experiments are necessary to address some interesting features that FDC1 
exhibits.  With the identification of a distinct spectrophotometric shift that results from  the 
formation of PrFMN dialkyl adducts it is possible to develop an assay to monitor the reaction 
between the PrFMN and the substrates.  Transient kinetics can be employed and by using the 
diverse operating conditions of FDC1 to determine the rates of formation of these short-lived 
PrFMN-substrate and PrFMN-product intermediates for non-ideal substrates including 
unsaturated linear substrates such as; sorbic acid and aromatic substrates such as 2-indole 
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carboxyalates.  Determining the rates of the formation and breakdown of these adducts would 
allow for researchers uncover the in vitro energetics of these reactions and compare those 
experimentally determined energetics to the energetics generated in silico for a variety of 
substrate types.  To accomplish this a researcher would need to select an appropriate substrate 
with slow, steady-state kinetics, and appropriate environmental conditions including pH and 
temperature controls. 
 Transient kinetics could probe several individual steps of the enzymatic mechanism using 
the same isotopically labeled substrates provided in chapter 3; these could be combined with 
using an isotope ratio mass spectrometry to probe the isotope effect of decarboxylation using 
natural abundance 
13
C effects for a complete suite of isotope effect experiments.  Given the 
reversible nature of reaction, stopped flow experiments and natural abundance 
13
C isotope effect 
experiments can be performed on both the forward and the reverse directions for the FDC1.  By 
combining these results with the primary solvent isotope effect established by an internal 
competition experiment in chapter 2 every chemical step of the reaction could be effectively 
probed.  The Hammett analysis, and isotope effects previously established that a chemical step is  
rate-determining in the reaction.   
 
5.2.2. Identifying Other Small Molecules that Potentially Bind to FDC1 
  An open question that needs to be further investigated is the identity of the 683, 667, and 
645 mass peaks representing the protonated, sodium, and potassium adducts of a small molecule 
with a mass of 644 daltons. Analysis of common mass spectrometry contaminants as well as 
common biological metabolites yielded no explanation for the 644-Da peak. The gentle tandem 
mass spectrometry conditions of the experiments above provide assurances that these peaks are 
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small molecules that are bound to the protein rather than peptide fragments. These peaks could 
represent a phenylaldehyde-PrFMN adduct or some other small molecule inherent to FDC1.  
These peaks are present in the wild-type FDC1 in a small amount, however upon mutating the 
active site the relative concentration of these small molecules increases, while the PrFMN mass 
peaks decrease.   Isolating and characterizing these intermediates may provide insight into the 
oxidative maturation of PrFMN if these species are indeed related to PrFMN, or provide insight 
to some secondary molecular species that is also intrinsically able to bind to FDC1.  Either of 
these outcomes would contribute to the understanding of the activation pathway FDC1 needs to 
undergo to become active in vivo. 
 Active site mutants of FDC1, E285A and E285Q exhibit a high level of these peaks 
compared to the wild type, and a comparatively low amount of PrFMN. The E285Q mutant 
would be good to crystallize since glutamine is a good isostere for glutamic acid. Thus the phase 
information of FDC1 would change little from the previously crystalized S. cerevisiae crystal 
structure.  This observation would allow for the phase information of the wild-type FDC1 to be 
applied to an E285Q FDC1 crystal structure.  The crystallization conditions for FDC1 were 
previously reported, thus providing a good starting point for experimental conditions that could 
be used to crystalize FDC1 mutants.  If these higher molecular weight species are indeed related 
to PrFMN, crystallographic evidence would provide the most direct answer, and should be 
explored. 
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5.2.3. Rational Engineering of FDC1 
 With the advances in the understanding of how FDC1 and the broader UbiD family 
undergo decarboxylation reactions, researchers now could begin improving the activity and 
broadening the substrate pool of FDC1 and, more broadly members of the UbiD family to make 
these enzymes more active as well as broaden the number of substrates these enzymes can 
decarboxylate.  With the crystal structure and the mechanism of FDC1 published computational 
modeling combined with enzyme engineering efforts could focus on expanding the substrate 
pool.  Manipulations of FDC could focus on the volume of the active site allowing for larger 
substrates, or perhaps constrain the active site to improve the activity of linear substrates such as 
sorbic acid, or 1,3 pentadionic acid. Some potential mutagenesis targets include mutating 
tryptophan in the substrate binding channel, or I330 or F440 to alter the active site space to allow 
for additional substrates to react or change the preferred substrate. Researchers could also 
engineer the PrFMN to modulate the activity of members of the UbiD family. 
 
5.2.4. Develop Inhibitors for UbiD Family Members in Bacteria or Fungi 
 The work presented previously provides insight on how to inhibit FDC1, a model enzyme 
of the UbiD family, using a substrate analog, FNVB.  This inhibitor provides a starting scaffold 
for the development of novel therapeutics targeting bacterial UbiD family members.  The nitro 
group serves as an acceptable isostere for carboxylate, however this can be further explored by 
switching out the terminal nitro group with a sulfonate or phosphate group have been shown to 
be isosteres of carboxylate groups.  Additionally, the Hammett analysis provides insight into 
how various functionalities of the ring impact the reaction, which can be exploited to develop 
better inhibitors.  Finally, the assays presented in chapter 4 offer methods to confirm covalent 
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inhibition of FDC1.   The assays presented as well as the confirmed inhibitor can also be used as 
a scaffold to develop and confirm more potent FDC1 inhibitors, which would directly target the 
resistance mechanism of ruminant species to naturally abundant antibiotic compounds such as 
ferulic, or cinnamic acid.   
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APPENDICIES 
 
Appendix A.1. FDC1 & PAD1 Gene Sequence and Mutagenesis Primers 
 
FDC1 Gene Sequence 
 
ATGCGCAAACTGAACCCGGNNNNNNNNTTCCGTGATTTTATCCAAGTCCTGAAAGA
TGAAGATGACCTGATTGAAATTACCGAAGAAATTGATCCGAACCTGGAAGTTGGCG
CAATCATGCGTAAAGCTTATGAATCACACCTGCCGGCGCCGCTGTTTAAAAATCTGA
AAGGTGCCAGTAAAGACCTGTTTAGCATTCTGGGCTGCCCGGCGGGTCTGCGTTCGA
AAGAAAAAGGCGACCATGGTCGCATTGCCCATCACCTGGGCCTGGACCCGAAAACC
ACGATCAAAGAAATTATCG 
ACTATCTGCTGGAATGCAAAGAAAAAGAACCGCTGCCGCCGATCACGGTTCCGGTC
AGCTCTGCGCCGTGTAAAACCCATATTCTGAGCGAAGAAAAAATCCACCTGCAGTCT
CTGCCGACGCCGTACCTGCACGTTAGTGATGGCGGTAAATATCTGCAGACCTACGGT
ATGTGGATTCTGCAAACCCCGGACAAAAAATGGACGAACTGGTCCATCGCACGTGG
CATGGTGGTTGATGACAAACACATTACCGGTCTGGTGATCAAACCGCAGCATATTCG
CCAAATCGCGGATAGCTGGGCGGCCATTGGCAAAGCGAATGAAATCCCGTTTGCAC
TGTGCTTCGGTGTGCCGCCGGCAGCTATTCTGGTTAGCTCCATGCCGATCCCGGAAG
GCGTTAGCGAATCTGATTATGTCGGCGCGATTCTGGGTGAAAGTGTTCCGGTCGTGA
AATGTGAAACCAACGACCTGATGGTCCCGGCCACGAGTGAAATGGTGTTTGAAGGT
ACCCTGTCCCTGACCGATACGCATCTGGAAGGCCCGTTTGGTGAAATGCACGGCTAC
GTTTTCAAAAGCCAGGGTCATCCGTGCCCGCTGTATACCGTCAAAGCAATGTCATAC
CGTGATAACGCTATTCTGCCGGTGTCGAATCCGGGCCTGTGTACGGACGAAACCC 
ATACGCTGATCGGTAGCCTGGTGGCAACCGAAGCTAAAGAACTGGCAATTGAATCT
GGCCTGCCGATCCTGGATGCTTTTATGCCGTATGAAGCGCAGGCCCTGTGGCTGATT
CTGAAAGTTGACCTGAAAGGTCTGCAAGCCCTGAAAAC 
CACGCCGGAAGAATTCTGCAAAAAAGTCGGCGATATTTATTTTCGCACCAAAGTGG
GTTTCATCGTTCACGAAATTATCCTGGTGGCAGATGACATCGACATCTTCAACTTCA
AAGAAGTCATTTGGGCTTACGTGACCCGTCATACGCCGGTTGCGGATCAGATGGCCT
TTGATGACGTCACCTCATTTCCGCTGGCACCGTTCGTGTCACAATCATCGCGCTCGA
AA 
ACGATGAAAGGCGGTAAATGCGTGACCAACTGTATTTTTCGTCAGCAATATGAACGC
TCTTTCGATTACATCACCTGTAACTTCGAAAAAGGCTACCCGAAAGGTNNNNNNNN
NNNNNNNAATGAAAACTGGAAACGCTACGGTTACAA 
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tPAD1 Gene Sequence 
 
TGAGGAATTCCCTCTGAATATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCA
GCAGCCANCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATG
AAACGTATTGTGGTTGCGATCACCGGCGCCACGGGTGTTGCACTGGGCATTCGCCTG
CTGCAGGTCCTGAAAGAACTGAGCGTGAAACCCATCTGGTTATCTCTAAATGGGGTG
CGGCCACCATGA 
AATATGAAACGGATTGGGAACCGCACGACGTTGCAGCTCTGGCCACCAAAACGTAC
TCAGTTCGTGATGTCTCGGCATGCATTAGCTCTGGCAGCTTTCAACACGACGGTATG
ATCGTCGTGCCGTGTAGTATGAAATCCCTGGCGGCCATTCGTATCGGCTTCACCGAA
GATCTGATTACGCGCGCAGCTGACGTGTCTATCAAAGAAAACCGTAAACTGCTGCTG
GTTACCCGCGAAACGCCGCTGAGTTCCATTCATCTGGAAAATATGCTGAGCCTGTGC
CGCGCTGGCGTCATTATCTTTCCGCCGGTGCCGGCA 
TTCTATACCCGTCCGAAAAGTCTGCACGATCTGCTGGAACAGTCCGTGGGTCGCATC
CTGGACTGTTTCGGCATTCACGCTGACACGTTTCCGCGCTGGGAAGGTATCAAATCA
AAATAAGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACC
ACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTG
GCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGGCCTCTAAACGGG
GTCTTGAGGGGTTTTTTTGCTGAAAGGAGGGAACTATATCCGGGATTGGCGAATGGG
ACGCGCCCTGTAGCGGCGCATTAACCGCGGCGGGTGTGGTGGTTACGCGCANCGTN
GACCGCTACACTTGCNAGCGCCCTANCGCCCGCTCCTTTTCGCTTTCTTTCCCTTCCT
TTTCTCGCCACGTTTCGCCCGGGNTT 
TCCCNGTCAAGCTCTAAATCGGGGGGGCTCCCTTTAAGGGGTTCCNNATTTTAGNGG
CTTTANCGGNNACCNNCNACCCCAAAAAAANTTGATTAGGGGNGAAGGTTTCNNNT
NAGNNGGGCCANCCCCCCNGAAAAAACGGTTTTTCCCCCTTTGANTTTGGGAAATCN
ANGTTTTTTTAAATANNGGA 
 
Appendix A.1.2. FDC1 Primer Sequences for FDC1 mutants 
 
 5’-TGGACGAACTGGTCCATCGCACGTGGCATGGTGGTTGATGACAAACACA-3’ 
R175A                  5’-GACGAACTGGTCCATCGCAGCTGGCATGGTG-3’ 
R175K                  5’-CGAACTGGTCCATCGCAAAGGGCATGGTGGTTGATGAC -3’ 
 
 
 
 
5’- CGCATCTGGAAGGCCCGTTTGGTGAAATGCACGGCTACGTTTTCAAAAGCCG - 3’ 
E285Q                     5’-GGAAGGCCCGTTTGGTCAGATGCACGGCTACGTTT-3’ 
E285A                                5’-GGCCCGTTTGGTGCAATGCACGGCTACG-3 
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Appendix A.2 Representative Purification of FDC1 WT enzyme and mutant FDC1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1      2 3  4       Elution 
Figure  A.1 Typical SDS gel of the FDC1 purification where lane 1 is the ladder, lane 2 is the cell lysate, lane 3 
is the flow-through, lane 4 is the wash, and the elution lanes are holo-FDC1 with a typical yield of 10mg/L and 
a purity of >95%  
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Appendix A.3 DNA Agarose Gel of FDC1 
 
 
Figure A.2. DNA gel with ladder in the far left lane, Lane 1: FDC1 standard, Lane 2 Pet28b empty vector, Lane 4 & 5 Duel 
construct Lanes 5-9 FDC1 mutant DNA linearization 
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Appendix A.4 Typical GC-MS spectrum of TCA and Styrene 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix A.4.1 Styrene Calibration Curve for GC-MS 
 
 
A 
B 
Figure A.3 Typical GC-MS result where A is the no – enzyme control where TCA presents at 10.25 minutes (B) Styrene 
peak present at 7.8 minutes 
Figure A.4. Styrene Calibration Curve for GC-MSanalysis 
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Appendix A.5 1d-Cinnamic Acid 
1
HNMR and Cinnamic Acid Product Standard 
 
 
 
A 
B 
A 
B 
Figure A.5 1d-TCA NMR with a singlet at 7.79 ppm and a disappearance of the doublet a 6.48 and 6.44 ppm  
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A 
B 
A B 
Figure A.6 TCA NMR with a doublet at 7.79 and 7.83 ppm a doublet a 6.48 and 6.44 ppm  
 
